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This study was centred on investigating the action of disintegrants and their 
roles in rapidly disintegrating tablets (RDTs) by visiometric, calorimetric, 
computational fluid dynamics (CFD) and quality by design (QbD) approaches. 
  
The first part of this study reports the use of high-speed video imaging to 
visualise and elucidate the mechanisms of action of disintegrants when 
incorporated into compacts and as free disintegrant particles. Acquired images 
were processed using MATLAB and changes in the compact area and 
instantaneous motion of compacted particles on contact with water were 
analysed. The capillary action of compacts was determined for various 
disintegrants. The break-up behaviour of compacts prepared at different 
compression pressure with selected disintegrants was also analysed. The results 
from this visualisation study provided an in-depth understanding of the 
disintegrant behaviour of free and compacted disintegrant particles upon 
wetting. The mechanisms of swelling, capillary action, disruption of particle-
particle bonds and strain recovery were successfully monitored. Solution 
calorimetry was also employed to further evaluate the heat of interaction 
phenomena of disintegrants. This particular study confirmed that all 
disintegrants are exothermic in nature. Also, structural and constitutional 
properties of disintegrants have direct effects on their enthalpy values. 
 
In the second part of the study, disintegration test apparatus, particularly 
suitable for RDTs were developed. The designed RDT disintegration apparatus 
consisted of disintegration compartment, stereomicroscope and video camera. 
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CFD was used to simulate different designs of the compartment. The simulation 
was validated to be in good agreement with the experimental results. 
Disintegration times of RDTs were determined using the designed RDT 
disintegration apparatus (I and II) and the USP disintegration apparatus. The 
results obtained using the designed apparatus (I and II) correlated well with 
those obtained by the USP disintegration apparatus. Thus, the applied CFD 
approach had the potential to predict the fluid hydrodynamics for the design of 
an optimal disintegration apparatus. The designed visiometric liquid jet-
mediated disintegration apparatus for RDTs provided efficient and precise 
determination of very short disintegration times of rapidly disintegrating dosage 
forms. 
 
In the last part of the study, functionality of disintegrants and their mixtures in 
RDTs were evaluated by a QbD approach. Ascorbic acid, aspirin and ibuprofen, 
which differ in water solubility, were chosen as the drug models. Disintegration 
time and hardness of RDTs were determined and modelled by using combined 
optimal design. The generated models were validated and used for further 
analysis. Graphical optimisation analysis demonstrated that the RDTs with 
desired disintegration times and hardness can be formulated with a larger area 
of design space by combining disintegrants at difference compression pressures. 
QbD is an efficient and effective paradigm in understanding formulation and 
process parameters and building quality into RDT systems. 
 
In summary, findings of this PhD project expanded the understanding of the 
properties of disintegrants and RDTs. 
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Tablet is the most common, preferred and convenient solid unit dosage form for 
patients, prepared by compaction (Kottke and Rudnic, 2002). Advantages of 
this dosage form include, accurate dosing, long shelf life and cost-effective 
production (Alderborn, 2001; Augsburger and Zellhofer, 2007). Most tablets 
manufactured are for oral administration although some tablets may be for other 
uses. They may be designed as immediate or modified release dosage forms by 
the use of suitable compositions and manufacturing techniques. Tablet 
compositions generally consist of active pharmaceutical ingredients (APIs) 
together with a wide range of other substances, commonly referred to as 
additives or excipients. Once administered to a patient, the tablet should release 
the API it contains in the required amount and rate. In some tablets, there may 
be two or more APIs. Excipients play a vital role in the design of the tablet 
dosage form by determining its functionality and performance. Excipients are 
generally regarded as pharmaceutically “inactive” ingredients added with APIs 
during formulation but they often have important specific functions. They are 
natural, semisynthetic or synthetic substances and some of the important 
features of excipients are listed below.  
 Excipients must be physiologically inert and when incorporated into the 
dosage form, remain physically and chemically stable throughout the 
required shelf-life of the dosage form. 
 Excipients must not introduce microbiological contamination.  
 Excipients must be approved by regulatory authorities. 
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 Excipients must be commercially available and manufactured or 
processed according to required pharmaceutical standards (Bandelin, 
1989).  
 
The various excipients used in tablet formulations include disintegrants, fillers, 
binders, glidants, lubricants, antioxidants, ultraviolet absorbers, dissolution 
modifiers, absorbants, flavouring agents, colouring agents, controlled-release 
agents, wetting agents and preservatives (Augsburger and Zellhofer, 2007; 
Kottke and Rudnic, 2002). All these excipients may not be included in tablet 
formulations all the time and certain excipients are used only when expressly 
needed. For example, antioxidants and wetting agents are required to ensure 
stability and solubility of APIs in particular cases. A good tablet formulation is 
not the result of a random combination of excipients with API but by a 
systematic approach and a rational excipient selection to satisfy optimal drug 
dissolution, accuracy and uniformity of drug content, stability, patient 
acceptability and manufacturability (Augsburger and Zellhofer, 2007). A newer 
class of excipients called “co-processed” excipients is now increasingly being 
introduced. Co-processed excipients are made by combining two or more 
excipients in an optimised ratio to provide superior synergistic properties than 
the simple physical mixture of excipients (Garg et al., 2013). Co-processed 
excipients can reduce the number of raw materials and improve production 
consistency (Kottke and Rudnic, 2002).  
 
Despite being considered as physiologically inactive, excipients can have 
significant impact on the dosage form’s biopharmaceutical performance. 
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Among all the tablet excipients, disintegrants are most important as they ensure 
that tablets break up into smaller fragments in the aqueous environment of the 
stomach, followed by APIs’ dissolution and absorption (Moreton, 2008). 
Disintegrants in disintegrating tablets also help to promote moisture penetration 
to initiate the matrix break-up, dissolution and absorption (Figure 1).  
 
Figure 1.  Fate of a disintegrating tablet upon wetting. Adapted from Alderborn 
(2001); Kottke and Rudnic (2002) 
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Drugs in the tablets become bioavailable only when they dissolve after 
disintegration (Ingram and Lowenthal, 1966). The actual disintegration process 
can be subdivided into two stages. The disintegration of a tablet is first to form 
aggregates of primary particles and subsequently, their deaggregation into the 
primary particles. Some non-disintegrating tablets are produced with highly 
soluble APIs and excipients and would rapidly dissolve upon ingestion 
(Alderborn, 2001; Kottke and Rudnic, 2002). 
1.2 Disintegrants 
Disintegrants are essential in a disintegrating tablet formulation as they ensure 
break-up of the tablets when placed in an aqueous environment (Moreton, 
2008). The earlier known disintegrants (traditional disintegrants) are starch- and 
cellulose-based excipients such as pregelatinised starch, microcrystalline 
cellulose and low-substituted hydroxypropyl cellulose. Some clays (e.g. 
Veegum HV), gums (e.g. agar, guar, tragacanth) and resins (e.g. polacrilin 
potassium) can also be considered. Later, more efficient disintegrants were 
introduced and they are developed by chemical modifications of starch, 
cellulose and povidone. These are sometimes referred to as superdisintegrants. 
Superdisintegrants are more effective than the traditional disintegrants and act 
even at lower concentrations. Examples of superdisintegrants include 
croscarmellose sodium, crospovidone and sodium starch glycolate (El-
Barghouthi et al., 2008; Shah and Augsburger, 2001).  All disintegrants are 
hydrophilic but insoluble in water or gastrointestinal juices (Moreton, 2008). 
Effervescent couple can however also be considered as disintegrants but are 
soluble, thus an exception to the insolubility general rule. Effervescent couple 
is a combination of a soluble organic acid with inorganic carbonate or 
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bicarbonate. When this combination is moistened, carbon dioxide (CO2) is 
generated by chemical reaction and the volumetric air expansion helps in 
disintegration of the effervescent tablets. However, this disintegration system is 
not suitable for conventional tablets and it is very sensitive to moisture. Another 
material class, inorganic carbonates can be considered as secondary 
disintegrants as they help in tablet disintegration by reacting with the acidic 
juices in the stomach and generate CO2. Another reason for incorporating 
inorganic carbonates in formulations is to help in the processing and 
manufacturing steps of tablet dosage form (Moreton, 2008).   
1.2.1 Mechanisms of disintegrant action 
Many theories have been proposed for the mechanisms of disintegrant action 
but a full understanding of the disintegrant action is still deficient (El-
Barghouthi et al., 2008; Zhao and Augsburger, 2005b). Factors contributing to 
disintegrant action in tablets include swelling of disintegrant particles followed 
by force development, wicking, strain recovery, release of gas by acid-base 
reaction, heat of interaction, expansion of entrapped air and deformation or 
break-up of physicochemical bonds (Moreton, 2008). Among all disintegrant 
actions, swelling, wicking (capillary action) followed by disruption of particle-
particle bonds, and strain recovery are more commonly discussed in the 
literature. Earlier, researchers attempted to propose a universal disintegration 
mechanism to explain disintegrant action but later it became clear that different 
disintegrants functioned differently. In most cases, it is believed that a 
synergistic combination of mechanisms is responsible. However, the relative 
prominence, rate and extent to which any of these mechanisms occur vary from 
one disintegrant to another (Sallam et al., 1998; Shah and Augsburger, 2001). 
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With whatever mechanism disintegrants work, their main function is primarily 
to separate or break up the tablet matrix in aqueous medium. In general, 
insoluble disintegrants perform more efficiently when formulated with 
insoluble fillers (e.g. dicalcium phosphate) than with soluble fillers (e.g. lactose 
and mannitol). Also, the method for adding disintegrants into the tablet 
formulation is important, particularly for disintegrating tablets prepared via wet 
granulation (Kottke and Rudnic, 2002). It was reported that disintegrants 
incorporated as both intra and extra granular fractions achieved the best overall 
disintegration performance (Bandelin, 1989). 
1.2.1.1 Swelling 
The swelling of starch- or cellulose-based disintegrants is possibly the best 
known mechanism for tablet disintegration (Alebiowu and Itiola, 2003; El-
Barghouthi et al., 2008). Swelling enlarges particle omni-directionally and 
separate the adjacent materials apart, thereby causing the tablet matrix to break 
up (Quodbach et al., 2014). The schematic of swelling mechanism is depicted 
in Figure 2. Most disintegrants swell to some extent and therefore, the swelling 
mechanism has been well reported (Kottke and Rudnic, 2002). The amount of 
swelling in a disintegrant depends upon many factors which include its chemical 
structure and the degree of crosslinking (Moreton, 2008). The porosity in tablet 
matrix also plays a very important role for swelling disintegrants. If the tablet 
matrix is more porous, with large void spaces, the swelling action may not exert 
sufficient force to the surrounding matrix and thus, tablet disintegration might 
be impeded. Tablets should be optimally compressed to be rigid enough for 
handling but on ingestion, disintegrants can impart swelling force to disintegrate 
the matrix. Very high compression pressures will result in low porosity tablets. 
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Disintegration medium cannot penetrate low porosity matrix rapidly and 
disintegration time may be prolonged. 
 
Figure 2. Schematic diagram of swelling mechanism 
A correlation was observed between the rate of disintegration force 
development and the disintegration time but not between the extent of 
disintegrant swelling and the maximum disintegration force. Thus, the rate of 
disintegration force development is critical for rapid disintegration (Augsburger 
et al., 2007; Colombo et al., 1984). Also, concentration of disintegrant used in 
a formulation is important. Some swelling excipients become gelatinised after 
swelling and can resist tablet disintegration. This is one of the reasons why gums 
such as agar, karaya and tragacanth are not very effective disintegrants (Kottke 
and Rudnic, 2002).  The swelling process for some disintegrants depends on the 
pH of the medium. Sedimentation volumes of cross-linked starch and cellulose 
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were effected by acidic pH whereas crospovidone and pregelatinised starch 
were unaffected (Shangraw et al., 1980). In another study, Chen et al. (1997) 
observed that the disintegration rate of tablets containing sodium starch 
glycolate or croscarmellose sodium was decreased in acidic media. However, 
disintegration rate of tablets containing crospovidone was not affected.  
1.2.1.2 Wicking 
Wicking is the spontaneous response action when material-air or material-
material interface is replaced by a material-liquid interface, commonly 
visualised as a “whipping” action (De Schoenmaker et al., 2011). Wickability 
is defined as the ability to maintain capillary flow and sometimes referred to as 
“capillarity” or “capillary flow” (Kissa, 1996). The schematic of wicking 
mechanism is depicted in Figure 3.   
 
Figure 3. Schematic diagram of wicking mechanism 
Apart from disintegrants, other tablet components may also confer 
hydrophilicity to the matrix and can help in tablet disintegration. In that sense, 
wicking cannot be considered as a primary disintegration mechanism. However, 
most researchers agree that water intake into the matrix is prerequisite to 
disintegrant activation (Moreton, 2008). If it is considered that wicking as an 
important requirement, then pore structure within the tablet will be critical and 
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be of prime importance. Capillary flow can be described by the Washburn’s 
equation (Augsburger et al., 2007):  
L2  = ( 
γcosϴ
2ƞ
) rt (Equation 1) 
where L is liquid penetration length into capillary, γ is the surface tension, ϴ is 
the solid-liquid contact angle, r is pore size, t is the time and ƞ is the liquid 
viscosity. 
 
Tortuosity factor, 𝑘, is included in the above equation to account for the 
penetration of disintegration medium into the powder bed and expressed as 
below.  
L2  = ( 
γcosϴ
2ƞ𝑘2
)  (Equation 2)  
Value of 𝑘 is unity for parallel capillaries whereas for a network comprising 
capillaries of different sizes, the proposed value for 𝑘 is up to 2.5 (Kissa, 1999). 
Thus, the resultant equation shows that greater pore size should accommodate 
greater liquid uptake and therefore, faster disintegration. Conversely, increased 
packing density decreases the pore size and the volume of penetration. It can be 
hypothesized that the coarser particles should yield greater pore size. In a study 
by Rudnic et al. (1980), the disintegration efficiency was increased when using 
larger particle size disintegrants. 
 
Khan and Rhodes (1975) examined the water-sorption properties of major tablet 
disintegrants and concluded that the high efficiency of some disintegrants are 
due to their high rates of water uptake. On the other hand, Gissinger and Stamm 
(1980) reported that the formation of porous capillary network alone cannot 
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adequately explain the disintegration process and other factors (e.g. swelling 
force) are also important. Microcrystalline cellulose is often used in tablet 
formulations both as filler and disintegrant, and the mechanism of its 
disintegrant action is proposed to be a combination of wicking and disruption 
of particle-particle bonds (Moreton, 2008; Peck et al., 1989). Bele and Derle 
(2012) concluded that the main mechanism of disintegrant action of polacrilin 
potassium is by wicking. 
1.2.1.3 Strain recovery 
During tablet manufacturing, tablet constituents are subjected to a high 
compression pressure [in the mega Pascal (MPa) range] within the constrained 
space available in the die between the punches. During compaction, the powder 
particles are deformed and interparticulate bonds are forged. Strain recovery is 
the reversible viscoelastic process of deformation (Patel et al., 2007). When 
compacted particles are wetted, they may partially regain their original shape 
by mechanical activation and thus help in tablet disintegration (Moreton, 2008). 
Under this condition, the shape recovery process will be unidirectional and in 
the opposite direction of exerted compression pressure (Quodbach et al., 2014). 
The relaxation and recovery of the stressed particles give rise to volume 
expansion and breakage of bonds. Concomitantly, disintegration medium could 
also plasticise the disintegrant polymer and help polymer chains to adopt the 
most energetically favourable positions. The schematic of strain recovery 
mechanism is depicted in Figure 4. Hess (1978) reported the recovery of 
croscarmellose sodium particle shape on exposure to moisture. Improvements 
in swelling efficiency of starch particles (after compression) were observed in 
some cases (Kottke and Rudnic, 2002). On the other hand, Lowenthal (1972) 
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concluded that regaining the original shape of starch grains after compression 
is not considered as the mechanism of disintegrant action for this disintegrant. 
Obviously, complete understanding of this phenomenon is still lacking and 
requires further study. 
 
Figure 4. Schematic diagram of strain recovery mechanism 
1.2.1.4 Interruption of particle-particle bonds 
Interruption of particle-particle bonds can be considered as one of the most 
important disintegration phenomena and has played a significant role in tablet 
disintegration. Although a full understanding is still deficient, past studies have 
provided the basic information about this phenomenon. Three different bonding 
mechanisms have been suggested to be involved when pharmaceutical tablets 
are prepared: solid bridges, mechanical interlocking and intermolecular forces 
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active over various distances (Karehill and Nystrom, 1990). Among these 3 
different bonding types, intermolecular forces are considered to be the 
prevailing bonding type in compact formation (Ferrari et al., 1996; Karehill and 
Nystrom, 1990). One of the main tablet disintegration mechanisms is the 
interruption of these binding bonds when the tablet comes in contact with 
disintegration medium or gastrointestinal juices (Lowenthal, 1973; Moreton, 
2008). It has been suggested that the microcrystalline cellulose tablets 
disintegrate because of the interruption of intermolecular bonds holding the 
cellulose fibres together by water (Lowenthal, 1973). Different techniques have 
been explored by the researchers in their attempts to study and quantify the 
intermolecular bonds involved in tablet matrix interruption. Luangtana-anan et 
al. (1992) found a correlation between the disintegration time of tablets prepared 
using different materials and the intermolecular forces present in the tablets. In 
the study, contact angles of different materials with a series of disintegration 
media were measured to calculate Hamaker constants. These constants 
represented intermolecular forces for that particular material and disintegration 
medium. Disintegration time of the tablet increased when the value of Hamaker 
constant increased. However, the disintegration time of magnesium carbonate 
tablet did not fit into the above hypothesis. It was postulated that another 
supportive disintegration mechanism may be present in the tablet. Also, this 
technique could not differentiate swelling from the disruption of intermolecular 
forces if both are responsible for tablet disintegration. Ferrari et al. (1996) 
investigated the interruption of particle-particle bonds in pharmaceutical tablets 
by various disintegration media by correlating disintegration time with 
disintegration medium uptake and disintegration force development. However, 
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the study was limited to specific materials with known bonding characteristics. 
Additionally, the above mentioned techniques did not include the study of 
possible energy and heat changes that occur during the interruption of particle-
particle bonds and wetting of tablet constituents in the disintegration medium. 
1.2.1.5 Heat of interaction 
Exothermic (heat generation) or endothermic (heat absorption) interactions are 
manifested by materials on interaction with the aqueous medium. Exothermic 
properties are observed from the interaction of disintegrants with aqueous 
medium (Lowenthal, 1973). The generated heat can cause localized stress 
resulting from the expansion of air retained in the tablet dosage form and it can 
aid the disruption of the tablet matrix. Luangtana-anan et al. (1992) examined 
the enthalpy property using different disintegrants. However, some researchers 
suggested that the amount of heat generated is rather small and may not be 
sufficient to cause sufficient expansion of the trapped air to break up the tablet 
dosage form (List and Muazzam, 1979). Lowenthal (1973) also discussed that 
if heat generation was an important mechanism of tablet disintegration then a 
tablet can also break up during compression or ejection from the die since 
significant heat is produced during this tableting step. Caramella et al. (1989) 
observed that the increased temperature of the aqueous medium did not enhance 
the disintegration process in some tablet formulations. Moreover, endothermic 
properties are exhibited by some of the disintegrants (List and Muazzam, 1979). 
Thus, it is necessary to study heat of interaction mechanism to confirm if the 
proposed mechanism is important and if a thermodynamic model can be 
developed to correlate with the tablet disintegration process. 
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1.2.2 Review of tablet disintegrants 
This section consists of a short description of major disintegrants used in tablet 
dosage form. 
1.2.2.1 Starch and its derivatives 
Starch is the oldest and probably the most multifunctional excipient, and the 
first tablet disintegrant used by the pharmaceutical industry (Bandelin, 1989; 
Moreton, 2008). It is a carbohydrate polymer, found in many plants such as 
potato, corn, wheat, rice, tapioca, arrowroot, sorghum, enset and dioscorea 
(Moreton, 2008). The starch structure is made up of two main polysaccharides: 
soluble amylose and insoluble amylopectin (Figure 5). Amylose is a linear 
polymer chain of α 1-4 linked low molecular weight glucose units. Amylopectin 
composed of larger, branched polymer chains of α-glucose units with α 1-4 
linkages and α 1-6 linkages (Hausler, 2009; Moreton, 2008; Schwartz and 
Zelinskie, 1978). The exact structure of starch is somewhat varied. Proportion 
of the two types of polysaccharides vary according to the botanical source of 
the starch, e.g. amylose content of tapioca starch is reported from 17 - 21 %, 
potato starch from 22 - 25 % and corn starch from 22 - 30 % (Schwartz and 
Zelinskie, 1978). Swelling is the most accepted mechanism of action for this 
disintegrant. The versatility of starch as an excipient is that it can be used as a 
disintegrant, binder, diluent, glidant and thickening agent (Hausler, 2009). 
However, native starches do not necessarily have ideal properties for some of 
their reported functionalities. For example, high amounts of starch (10 - 15 %) 
may be required for starch to function well as a tablet disintegrant. Starches also 
do not possess good compressibility and may not perform well in direct 
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compression formulations. Physical and chemical modifications have been 
attempted to improve the properties of native starches (Moreton, 2008).  
   
 
 
Figure 5. Structural formula - amylose and amylopectin 
Pregelatinised starch is one such processed starch excipient in which partly or 
wholly, the starch grains are chemically or mechanically ruptured. The extent 
of pregelatinisation has significant impact on the physical attributes of starch as 
an excipient. Partial pregelatinisation improves the flowability and 
compressibility of starch while still retaining the disintegrant activity. Fully 
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pregelatinisation makes the starch excipient soluble in cold water. However, it 
is no longer an effective disintegrant and is more a tablet binder (Kibbe, 2009b; 
Moreton, 2008). A chemically modified starch excipient is sodium starch 
glycolate which is the sodium salt of cross-linked carboxymethylated starch 
(chemically modified starch, Figure 6). Sodium starch glycolate particles are 
generally spherical in shape and have good flowability (Augsburger et al., 
2007). Sodium starch glycolate functions as a superdisintegrant by very strong 
swelling. Concentration used for sodium starch glycolate ranges from 2 - 8 % 
(Young, 2009).  
 
 
Figure 6. Structural formula - sodium starch glycolate 
1.2.2.2 Cellulose and its derivatives 
Cellulose consists of a β 1-4 linked glucose polymer. Native celluloses consist 
of alternating tightly packed microcrystalline and less dense amorphous regions. 
Acid hydrolysis of cellulose degrades the polymer by attacking the amorphous 
regions but keeps the microcrystalline portions relatively intact. This reaction is 
used to prepare the widely used tablet excipient, microcrystalline cellulose. The 




Figure 7. Structural formula - microcrystalline cellulose 
After acid hydrolysis, the cellulose residue is purified by filtration and spray 
dried to form dry, porous microcrystalline cellulose (Guy, 2009; Moreton, 
2008). It can be used as a disintegrant, diluent or binder in tablet formulations. 
Microcrystalline cellulose as a tablet disintegrant acts by the combination of 
capillary action and separation of particle-particle interactions (Peck et al., 
1989). However, disintegration efficiency is not high and 20 %, w/w is the 
expected amount that may be needed to perform as an effective disintegrant. 
Low substituted hydroxypropyl cellulose is a modified hydrophilic, water 
insoluble cellulose (low substituted form of cellulose ether, Figure 8) which 
swells in water and can be used as a tablet disintegrant in the range of 2 - 10 % 
(Moreton, 2008). 
 
Another modified cellulose excipient is croscarmellose sodium, which is a 
cross-linked polymer of carboxymethyl cellulose sodium (Augsburger et al., 






R = H or [CH2CH(CH3)O]mH 
Figure 8. Structural formula - low-substituted hydroxypropyl cellulose 
 
Figure 9. Structural formula - croscarmellose sodium 
Croscarmellose sodium particles are long and narrow (fibrous) with curves and 
twists. Swelling, wicking and strain recovery mechanisms are proposed for this 
superdisintegrant action (Moreton, 2008).  It can be used up to 5 %, w/w in 
tablet formulations, usually 2 %, w/w is used in direct compression tablets and 




Crospovidone is a water insoluble synthetic cross-linked polyvinylpyrrolidone 
(Figure 10) manufactured by the proliferous polymerization of vinylpyrrolidone 
(Barabas and Adeyeye, 1996; Kibbe, 2009a).  
 
Figure 10. Structural formula - crospovidone 
Crospovidone possess a “popped” structure and by this creation, this polymer 
is also known as “popcorn” polymer. There are two accepted methods for 
crospovidone manufacturing. One method is to manufacture without the 
addition of crosslinking agent (crosslinking agent is formed in situ) and another 
method is to manufacture with crosslinking agent (Barabas and Adeyeye, 1996). 
Crospovidone grade with the coarsest particle size disintegrates tablet faster 
than smaller particle size grades (Shah and Augsburger, 2001). Amounts of 
crospovidone used in tablet formulations varied in literature reports. Generally, 
it is used in the range of 2 - 5 % in tablets prepared by direct compression and 
wet granulation methods (Kibbe, 2009a; Moreton, 2008).  There is no consensus 
in literature reports on the major mechanism of disintegrant action for the 
superdisintegrant, crospovidone. In the earlier reports, Kornblum and Stoopak 
(1973) suggested that crospovidone acted through capillary activity with a 
secondary swelling effect but did not conclude the overall mechanism of action. 
The proposed mechanism of disintegration by wicking (capillary action) was 
supported by several other investigators (Gohel et al., 2007; Gould and Tan, 
1985; Kalász and Antal, 2006; Martino et al., 2005; Shimizu et al., 2003; 
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Shiyani et al., 2008; Vromans et al., 1987). Fromming et al. (1981) reported that 
crospovidone exhibited an exceptionally high swelling pressure, associated with 
the increased hydration capacity of the polymer which had contributed to its 
disintegrant action. List and Muazzam (1979) concluded that neither capillarity 
nor the heat of adsorption were responsible for the degree of disintegration but 
swelling pressure was the main mechanism of disintegration for crospovidone 
and starch-based materials. Other researchers commented that the insoluble 
crospovidone had a high swelling capacity (Shu et al., 2002). During tablet 
compaction, the disintegrants are subjected to a high compression pressure, 
resulting in deformation. A more recent report found that crospovidone did not 
swell and proposed that recovery of energy of viscoelastic deformation was 
responsible for the disintegration of crospovidone containing compacts, 
together with capillary action and disruption of particle-particle bonds 
(Moreton, 2008). Findings from several research groups indirectly supported 
this proposed disintegrant mechanism for crospovidone. An example is by Khan 
and Rooke (1976) who found that tablets of crospovidone and dicalcium 
phosphate dihydrate or other diluents demonstrated better dissolution efficiency 
with increased tabletting pressure. Similarly, Martino et al. (2005) showed that 
low compression pressure and hardness dramatically decreased the 
disintegration of a formulation containing crospovidone. Nevertheless, many 
reports suggested that higher tablet hardness were generally detrimental to the 
disintegration of tablets prepared with commonly used disintegrants 
(Bronnsack, 1978). Thus, tablets made from crospovidone did not follow the 
general disintegration behaviour of tablets made with other common 
disintegrants. Collectively, the literature review did not provide any clear 
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explanation for the disintegrant mechanism of crospovidone as a tablet 
disintegrant. 
1.2.3 Quantification of disintegrant action 
Many approaches have been undertaken to quantify swelling, wettability and 
capillary action of free particles and compacts with the aim to elucidate 
disintegrant action. Enslin measured the water uptake by non-compacted porous 
powder beds. Water absorbed by the powder bed in the glass vessel was 
measured volumetrically. A calibrated pipette was used to determine the 
volumetric quantity accurately. Based upon measurements, Enslin number was 
calculated. Enslin number represents the amount (g) of liquid taken up by 1 g 
of powder (van Kamp et al., 1986). Swelling of powder beds or tablets and water 
uptake were sometimes used interchangeably. However, water uptake and 
penetration can be high without significant swelling. Therefore, penetration of 
water into powder bed (penetration depth) and swelling were measured 
separately by Nogami et al. (1969). Penetration depth was measured by the 
following method. First, the disintegrant powder was filled in graduated tube 
and mechanically tapped for 6 min. Next, the tapped tube was immersed into 
water and penetration depth was calculated. To measure water uptake and 
swelling of disintegrants, a test method and apparatus called water uptake 
apparatus was developed. Figure 11 shows the schematic diagram of the water 
uptake apparatus. Briefly, the disintegrant powder was packed into the 
graduated glass tube which was placed upon the moistened glass filter plate. 
Water from the graduated pipette was absorbed by the disintegrants and water 




Figure 11. Nogami apparatus for the quantification of water uptake and swelling 
of powder bed. Adapted from Nogami et al. (1969) 
Other researchers had used similar apparatus for water uptake study (Gissinger 
and Stamm, 1980; Marshall et al., 1991; Rudnic et al., 1982). van Kamp et al. 
(1986) made improvements to the water uptake apparatus design to measure 
water uptake of tablet or powder bed by making measurements easier, fast and 
reproducible.  The main parts of the re-designed apparatus included a glass tube 
(with glass filter at the lower side) to place tablet or powder, graduated burette 
(connected with glass tube) filled with water, reservoir for supply of water, 
microbalance to record weight loss during water uptake and interface with 
computer connected to microbalance to record all results (Figure 12). 
 
Caramella et al. (1990) determined the swelling or disintegrating force 
developed inside the tablet along with water uptake and evaluated swelling 
efficiency. A parameter “equivalent force” was proposed to denote the 





Figure 12. van Kamp apparatus for the quantification of water uptake (van 
Kamp et al., 1986) 
Swelling capacity of a disintegrant (bulk swelling) was simply determined by 
filling a fixed amount (by weight) of disintegrant in a graduated cylinder and 
shaking the disintegrant with water until all particles were well dispersed. The 
sedimentation volume of disintegrant was measured after a day to calculate the 
swelling capacity (ratio of the swollen volume to bulk volume) of disintegrant 
(Visavarungroj et al., 1990; Visavarungroj and Remon, 1990). Water infiltration 
rates into different disintegrant materials at tapped densities were also measured 
by capillary rise experiments in which rates were determined by measuring the 
speeds of ascending colour solutions entering the sample columns from bottom 
to top (Rashid et al., 2009). Contact angle measurements were other methods 
used to measure wetting properties of excipients (Schreiner et al., 2005). Coulter 
counter technique was also used to measure the individual particle swelling 
(Caramella et al., 1990). 
 
Image analysis is another way to visually quantify disintegrant action and has 
been used for eliciting disintegrant mechanisms such as swelling, wicking and 
deformation. Lowenthal (1972) studied the deformation of starch grains using 
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the light microscope and scanning electron microscope. Wan and Prasad (1990) 
measured the swelling of tablet disintegrants using a video camera recording 
system mounted on a microscope. A new technique based on image analysis 
was developed to study water uptake in tablets (Le Néel et al., 1997). The 
fabricated wetting apparatus and the image analysis algorithm enabled the 
visualisation with simultaneous thickness and diameter quantifications. The 
results shared that the types of disintegrants and their concentration change 
tablet swelling (particularly the axial component of tablet). The researchers 
concluded that the image analysis based technique is a rapid and accurate 
method to study tablet swelling. Quodbach et al. (2014) used real-time magnetic 
resonance imaging (MRI) to evaluate the disintegration phenomena of tablets 
containing commonly used disintegrants and concluded that real-time MRI 
could be a useful tool to achieve dynamic visualisation for understanding 
disintegration phenomena. High-speed video recording followed by image 
analysis is a fast developing and increasingly popular technique to record and 
analyse motion based phenomena (Parkkali et al., 2000). The imaging technique 
offers accuracy, versatility, rapidity and ease of manipulation with relatively 
affordable one time instrument cost. Imaging techniques have been used to 
examine the swelling of disintegrant particles (Moussa and Cartilier, 1996; 
Rudnic et al., 1982; Shah and Augsburger, 2001) and to visualise compact 
disintegration as well as particle dynamics (Lindeboom et al., 2011; Zhao and 
Augsburger, 2005a). Different research fields (such as biology, archaeology, 
geology, pharmacy, materials science and medicine) have applied methods 
based on image analysis to understand different motion based phenomena 
(Parkkali et al., 2000). Therefore, high-speed video imaging followed by image 
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analysis is a useful technique for adoption to unravel morphological and mobile 
changes of disintegrants in their disintegration mechanisms.  
1.2.4 Evaluation of tablet disintegration 
Tablet disintegration can be considered as the most important event before drug 
dissolution which in turn is often considered as the surrogate of drug absorption. 
This criterion is generally applicable to most cases of drugs and formulations 
but cannot be generalised for all. Tablet disintegration is more often employed 
by the pharmaceutical industry as an in-process control test and the evaluation 
is most useful during formulation development for the optimisation of tablet 
formulations. Pharmacopoeias of different countries have included clear 
information about the tablet disintegration test apparatus and method of testing. 
For example, USP disintegration apparatus consists of a basket-rack assembly, 
beaker of particular dimensions, heating system and a hanger with a mechanism 
for raising and lowering the basket-rack assembly. The basket-rack assembly 
contains six tubes with metal mesh at the bottom and optional disks to hold 
down dosage forms. The operation of the disintegration apparatus is simple. 
Beaker is filled with disintegration medium and temperature of disintegration 
medium is controlled using a thermostatic bath or heating system. A tablet is 
placed in each tube of the raised basket-rack assembly. The assembly is lowered 
and oscillated vertically at a fixed speed in the disintegration medium and the 
time required for all the disintegrated tablet fragments to pass through the mesh 
is reached and recorded for each tablet (Moreton, 2008; Qureshi, 2007). 
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1.3 Rapidly disintegrating tablets (RDTs) 
Conventional tablets and capsules sometimes are inconvenient, even difficult to 
be administered to certain groups of users like those on the move, those who 
have swallowing difficulties as well as geriatric, paediatric, bedridden and 
mentally challenged patients (Fu et al., 2005; Giri et al., 2010; Goel et al., 
2008a; Jeong et al., 2005; Pfister and Ghosh, 2005; Saigal et al., 2008; Sandri 
et al., 2006). Liquid dosage forms have the benefits of greater ease of 
administration by comparison with solid dosage forms but have the 
disadvantages of poorer stability, being bulkier and having less precise dosing. 
Patients usually prefer compact products which can be consumed without the 
need of water. RDTs can be regarded as products that are ideal to consumers.  
 
RDT is an oral solid dosage form which disintegrates or disperses instantly upon 
wetting with saliva in the buccal cavity and can be ingested without the need of 
water (Battu et al., 2007; Giri et al., 2010; Goel et al., 2008a; Jeong et al., 2005; 
Saigal et al., 2008; Sandri et al., 2006). It is also known as orally disintegrating, 
orodispersible, fast disintegrating, fast dispersing, rapid dissolving, fast melting 
or mouth dissolving tablets. The United States Food and Drug Administration 
(US-FDA) defined an RDT as "a solid dosage form containing medicinal 
substance or active ingredient which disintegrates rapidly usually within a 
matter of seconds when placed upon the tongue" (US-FDA, 2008). RDTs 
provide the convenience afforded by both solid and liquid dosage forms. RDTs 
are advantageous to patients with dysphagia or swallowing difficulties such as 
paediatric, geriatric, stroke, Parkinson’s disease or cerebral palsy patients as 
well as those who have undergone head/neck radiation therapy. Travellers who 
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do not have easy access to water can also benefit from RDTs (Douroumis, 2011; 
Fu et al., 2005; Goel et al., 2008b; Haware et al., 2008). Furthermore, RDTs 
provide the opportunity for companies facing the end of patent protection for 
their products (Jeong et al., 2005; Saigal et al., 2008). RDTs are increasingly 
being introduced into the market. Market studies have indicated that more than 
half of patients studied prefer RDTs to other dosage forms (Deepak, 2004). The 
growth in popularity reflects their acceptance by the public. However, a 
difficulty faced in RDT formulation development is the relative product cost 
since RDT formulation and manufacturing involve the use of both expensive 
excipients and less efficient technologies (Battu et al., 2007). With rapid matrix 
break-up, issues related to taste enhancement for bitter drugs and palatability 
are some of the major challenges to be overcome in the formulation of this 
dosage form. Judicious innovations to use cheap excipients or less of the 
expensive excipients and processes with conventional technologies can provide 
cost effective solution to formulate good quality yet affordable RDTs for 
general public use. 
1.3.1 Formulation of RDTs 
An ideal RDT should have all the parameters of a conventional tablet (e.g. 
hardness, friability, stability, content uniformity) with the additional attribute of 
rapid disintegration for the convenience of oral dispersion (Goel et al., 2008a; 
Saigal et al., 2008). It should not have bad taste nor gritty mouth-feel. 
Fundamental approaches to develop an RDT formulation require maximization 
of the porous structure of the tablet matrix and integration of suitable 
disintegrating agents and/or highly water-soluble excipients in the formulation 
to bring about rapid disintegration and dissolution (Goel et al., 2008a; Saigal et 
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al., 2008). RDTs can be categorized into three basic groups according to the 
method employed in their preparation, i.e. freeze-drying, moulding and 
compression (Sandri et al., 2006).  
 
In the freeze-drying method, a solution or suspension of drugs with specific 
additives is filled into shaping pockets and solvent is removed by freeze-drying 
to produce tablets with highly porous matrices. Rapid disintegration is the major 
advantage of RDTs produced by this method. However, friability, moisture 
sensitivity, difficulty in taste masking and packaging cost are some of the 
common issues that need to be resolved (Okuda et al., 2009; Sandri et al., 2006). 
An alternative RDT preparation is by the moulding method which can be further 
subdivided into solvent or heat moulding (Sandri et al., 2006). By the solvent 
moulding method, drug solution or suspension is first evaporated using vacuum 
and the remaining matrix is further dried at about 30°C. In the heat moulding 
method, saccharides are used in the formulation. These carbohydrates are 
converted into amorphous floss by the simultaneous action of flash heating and 
centrifugal force. The resultant matrix is cured, milled and blended with drug 
compounds and other excipients and then compressed using conventional 
compression technology. Moulded tablets are generally soft, friable and 
moisture sensitive. These delicate features demand highly specialized 
packaging (Sandri et al., 2006). A third approach to produce RDTs is by the 
normal compression method. This can be further sub-divided into two 
categories requiring granulation (wet, dry or melt) followed by compression and 
direct compression. With the well-established tablet technology, it would be 
easier for technology transfer and a low manufacturing unit cost can be the main 
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advantage with the compression methods. However, disintegration time is liable 
to be longer in comparison with RDTs produced by the other technologies 
(Sandri et al., 2006). Examples of commercially available RDTs manufactured 
by all these technologies are given in Table 1. 
Table 1. Examples of commercial RDTs manufactured by different 
technologies. Adapted from Saigal et al. (2008); Sandri et al. (2006) 
Technologies employed to 
manufacture RDTs 
Commercial RDTs 






Granulation followed by 
compression 
 
WowTab®, FlashTab®, Frosta® 
 
Direct compression 
OraSolv®, DuraSolv®, OraVescent®, QDis™, 
Ziplets®, AdvaTab™ 
 
Continuous improvements in RDT formulation and production technologies 
will be required for potential products to be developed (Goel et al., 2008a). 
Although the above discussed technologies fulfil RDT requirements to some 
degree, most do not have all the desired features (Fu et al., 2005). Understanding 
the disintegration mechanisms of currently available disintegrants, especially in 
the development of RDTs, could help in optimising RDT formulations by 
bringing about rapid matrix break-up. 
 
RDT formulations to be manufactured by the compression method require the 
efficient selection of disintegrant combinations to enhance the break-up of 
tablets when in contact with water. The effectiveness of disintegrants in RDT 
formulations has been well studied. Haware et al. (2008) reported the 
effectiveness of croscarmellose sodium, crospovidone and sodium starch 
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glycolate at different concentrations. Douroumis et al. (2011) reported the 
effects of compression force on cetirizine RDTs formulated with several 
superdisintegrants. Martino et al. (2005) studied the effects of compression 
pressure on disintegration with different disintegrants. Some reports examined 
the effects of superdisintegrants using a single drug compound (Douroumis et 
al., 2011; Kasliwal et al., 2011; Zhao and Augsburger, 2005a). 
1.3.2 Disintegration rate measurements of RDTs  
One of the most important features of the RDT is its short disintegration time 
(Narazaki et al., 2004). Disintegration time could be evaluated in vivo by several 
methods (Bi et al., 1996; Ishikawa et al., 1999; Koizumi et al., 1997; Watanabe 
et al., 1995). However, results of such in vivo tests are not as reproducible for 
RDTs in comparison with conventional tablets because the very short 
disintegration times of RDTs generally differ only by seconds. Also, in vivo 
disintegration testing requires rigid regulatory approval. Thus, a reliable and 
sensitive in vitro disintegration test for RDTs is required, especially for routine 
quality control purposes. However, no specific pharmacopoeial apparatus has 
been identified for determining the disintegration times of RDTs. It is often 
difficult to precisely determine the disintegration time of RDTs using United 
States Pharmacopeia (USP) disintegration apparatus when the RDT 
disintegration process is usually very rapid. Moreover, USP disintegration 
apparatus has limitations when discriminating between disintegration times of 
different RDTs (El-Arini and Clas, 2002; Harada et al., 2006; Morita et al., 
2002; Narazaki et al., 2004; Shukla et al., 2009). Thus, it is necessary to develop 
a disintegration apparatus capable of determining precisely the disintegration 
times of RDTs. Various disintegration apparatus have been developed to 
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address some of the limitations present in the USP disintegration apparatus. 
Most of these proposed methods are based on the application of mechanical 
stress on to the RDT. For example, in JP 2010-164415, Akira et al. (2010) 
described an apparatus, wherein, the tablet is placed on the flat bottom surface 
of the holder and load was applied by a rod and hollow cylinder onto the tablet. 
Disintegration medium of specified volume is used to wet the tablet. Based on 
tablet strength and degree of tablet disintegration, the rod and hollow cylinder 
descend and provide sufficient load to the central and peripheral parts of the 
tablet. A downward halt of the rod and cylinder is taken to determine the 
disintegration end point. Ooraku et al. (2001) in JP 2001-141718 described an 
apparatus with load applied on the tablet held in the container with the tablet 
dipped into a solution. The time required for the moistened tablet to collapse is 
considered as disintegration time for the tablet. Another disintegration apparatus 
was described with the application of mechanical stress (Narazaki et al., 2004). 
The RDT on a stainless steel wire gauze was slightly immersed in the 
disintegration medium and then compressed by a shaft, crushing the 
disintegrating RDT through the gauze into the medium. The endpoint was 
determined by a manual timer. Harada and Narasaki (2004) disclosed a 
disintegration apparatus in JP 2004-233332 designed with a support base to 
accommodate the tablet in the vicinity of the disintegration medium level and a 
pressure tool to apply pressure on the tablet. The support base holds the 
disintegrating tablet with a pressure applied by the rotating pressure tool. When 
the lower surface of the pressure tool comes in contact with the upper surface 
of the tablet support base, tablet disintegration is considered to be completed. 
In JP 2008-082877, another disintegration apparatus was proposed by Harada 
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(2008). The apparatus consists of a chamber to store the disintegration medium, 
a conductive perforated plate, a tablet holder, two or more weights for pressing 
the tablet, a driving device and a detector. The disintegration medium is spread 
over the surface of the perforated plate and the tablet is crushed by the use of 
weights. At the same time, the driving device is used to move the tablet 
simultaneously in the horizontal direction. When the tablet disintegrates, the 
weight(s) and perforated plate come in contact with each other, generating a 
signal which indicates the disintegration end point. Disintegration apparatus 
discussed by Yoshifumi (2008) in JP 2008-064620 follows a similar principle. 
The apparatus is equipped with a drum support which can be rotated and has a 
seat to hold the tablet, a supply of a small amount of disintegration medium and 
a weight for pressing the tablet. The frictional force generated by the weight on 
the tablet is responsible for collapsing the tablet. The texture analyser 
instrument was also utilized by applying a constant force on the tablet, attached 
to the bottom of a cylindrical probe and immersed in distilled water (Dor and 
Fix, 2000). The distance travelled by the probe due to the applied force was 
measured. The common drawbacks of the various proposed disintegration 
apparatus which are based on the application of mechanical stress include 
complicated apparatus design, need for optimisation of several parameters and 
inherent errors associated with the application of mechanical force onto often 
very soft disintegrating RDTs or rather small size dosage forms. 
 
Another approach to study RDT disintegration process includes the application 
of liquid medium with sufficient stirring or agitation to the RDT. A modified 
dissolution apparatus was suggested by Bi et al. (1996) where the disintegration 
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medium was stirred using a paddle and the time required for the tablet fragments 
to pass through the screen of the sinker was determined as disintegration time. 
Morita et al. (2002) suggested a disintegration apparatus in which the RDT, 
placed over a stainless steel grid, disintegrates in a mildly agitated medium and 
the process is captured by a CCD camera. In the disintegration test apparatus 
and method discussed in JP 2008-032482, the RDT is placed on a mesh and the 
disintegration medium from a temperature controlled bath is drained onto the 
RDT to determine its disintegration (Hoashi et al., 2008). However, this 
approach does not consider the possible mechanical stress which is applied to 
the RDT when placed inside the mouth and the movement of tablet inside the 
oral cavity. Thus, a disintegration test method and apparatus which can evaluate 
disintegration process of RDTs or fast disintegrating dosage forms in a simple, 
accurate and reproducible manner and thus suitable for routine quality control 
purposes is still deficient. 
1.4 Experimental tools used to understand disintegrant action and 
disintegration of RDTs 
1.4.1 Particle image velocimetry (PIV) 
Currently, PIV is the most widely used technique to provide the velocity profiles 
of liquids, gases or fluid like flows of solids (Fouras et al., 2009; Li and Hishida, 
2009). PIV is used to study low speed and supersonic flows, flows in the area 
of nano-scaled passage under a microscope and wider scaled passage like big 
rivers and current flows, single phase as well as multiple phases, flows related 
to inanimate objects and living beings, fluid mechanics and aerodynamics 
(Fouras et al., 2009; Li and Hishida, 2009). According to its name, the technique 
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is based upon image capturing and analysis. Some form of light (e.g. laser light) 
is used to visualise the area of interest and a camera is used to capture the real-
time images. PIV requires sequential images of the flow field and these images 
are then divided into sub-images (also referred as a grid-like set of uniformly 
spaced regions or interrogation spots). Instantaneous velocity vector 
measurements and displacement of the sub-images are decided by searching the 
highest image similarity between the original sub-image position and the best 
matched position in the following frame (Fouras et al., 2009; Wang et al., 2010a, 
b; Wereley and Meinhart, 2010). The extent of similarity between sub-images 
can be elucidated by different techniques and include cross-correlation and 
minimum quadratic difference (MQD). MQD technique can also be used when 
single particles cannot be differentiated and is more accurate and robust than 
the other techniques (Gui and Merzkirch, 1996; Suh, 2003). On the other hand, 
more computational time is required for MQD in comparison with cross-
correlation.  
Quadratic difference can be calculated using MQD as follows: 
𝐶(∆X, ∆Y) = ∑ .𝑁𝑖=1 ∑ |f1(Xi, Yj) − f2 
𝑁
𝑗=1
(Xi + ∆X, Yj +  ∆Y)|    (Equation 3) 
where Xi, Yj are the coordinates; ΔX, ΔY are the displacements along the 
coordinates; f1 and f2 are the first and second images, respectively (Suh, 2003; 
Wang et al., 2010b). Velocity vectors can be obtained on the basis of 
displacement and the time interval between the images. Velocity-time profiles 
and distance-time profiles can be further generated. 
 
If the area of interest is visible, then PIV allows the simultaneous measurement 
of velocity. A suitable setup can be established to capture the real-time 
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disintegration phenomena for analysis using the PIV technique. To date, PIV 
has not been used to uncover the disintegration phenomena and characterise 
disintegrants. 
1.4.2 Solution calorimetry 
Tablet disintegration process includes interruption of bonds between solid-solid 
tablet constituents and formation of bonds between solid constituents on wetting 
(Lowenthal, 1972; Moreton, 2008). During this process, energy and heat of the 
thermodynamic system are changed and these changes can be measured by the 
calorimetric technique. The term solution calorimetry is coined for the 
measurement of calorimetric processes which take place primarily in liquid 
medium at a certain temperature (Cordfunke and Ouweltjes, 1994). Solution 
calorimetry has been used in the pharmaceutical field to determine the 
amorphous contents of drugs and excipients (Gao and Rytting, 1997; Katainen 
et al., 2005), measure swelling of polymers (Conti et al., 2006) and analyse 
dissolution of polymers and nanosuspensions (Conti et al., 2006; Kayaert et al., 
2010). However, the application of solution calorimetry for understanding the 
tablet disintegration phenomena has not been reported. The technique can 
potentially provide information on the kinetics and energetics in the process of 
tablet disintegration associated with the preponderance of liquid-liquid and 
liquid-solid interactions. In a solution calorimetric experiment, the output is a 
composite of wetting, liquid penetration, disintegration phenomena and any 
other interaction process that might occur (Marabi et al., 2007). A wider range 
of temperature (278-348 K) can be used with sufficient accuracy in this 
technique (Mohite and Juvekar, 2009). The swelling component of the 
disintegrants is also associated with heat changes and the swelling component 
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is therefore amenable to be studied by this technique (Conti et al., 2006). It is 
hypothesised that correlation could be found between the temperature activity 
data obtained using solution calorimetry and the disintegration phenomena.  
1.4.3 Computational fluid dynamics (CFD)  
CFD is ideal for the characterisation of fluid hydrodynamics (Lee, 2011). From 
physical aspects, any fluid flow condition is governed by three conservation 
laws: a) conservation of chemical species, b) conservation of energy, and c) 
conservation of momentum. These laws can be represented by mathematical 
equations, mostly partial differential equations. CFD is a set of numerical 
(computational) approaches applied to calculate approximate solutions of the 
conservation laws describing fluid flow conditions. With advancement in 
computational technologies, user-friendly CFD software programmes are now 
available to researchers for use as a routine tool for engineering design, 
optimisation and analysis (Zikanov, 2010). CFD enables a better understanding 
of the velocity distribution, pressure distribution, heat transfer and other 
relevant parameters confined within the geometry. It analyses the impact on 
these parameters when the geometry is modified and thus allows alternative or 
improved design options. This computational technique complements physical 
modelling, reduces design time and expenses by decreasing the total cost of 
experimentation and laboratory or field testing. Some examples of major 
software programmes using the CFD concept and codes to solve the fluid flow 
problems include ANSYS FLUENT, STAR-CD, ANSYS CFX, CFD-ACE+, 
COSMOL and OpenFOAM (Ruzycki et al., 2013). All these products have 
different interfaces and capabilities but they generally work by numerically 
solving the partial differential equations describing the fluid flow conditions. 
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1.4.3.1 CFD simulation steps 
CFD simulation can be divided into three steps; 
a) pre-processing, 
b) solving, and  
c) post-processing. 
Pre-processing is the first step to building geometry to represent the problem in 
a physical sense. The geometry is then discretised with a grid or mesh into finite 
number of elements. This discretised structure is required since the governing 
equations of fluid flow will be solved later at the vicinity of each grid and the 
results obtained by solving these equations for each element are more accurate 
than solving for the whole geometry. The next step is to define boundary 
conditions. CFD problems are required to be formulated for finite domain 
limited by boundaries. Correctly-formulated problems should include proper 
boundary conditions for velocity, pressure, temperature and other variables. 
This generated geometry file is finally exported to the CFD solver. 
 
Solving is the step to solve the equations (generated at the vicinity of each grid) 
and compute numerical solution using an iteration method, until the 
convergence is obtained. FLUENT is a generic CFD solver used widely for this 
purpose. 
 
The post-processing step will analyse and visualise the results as vectors, 
contours and pathline plots. The key concern of this step is how to generate the 




The user friendly interface of CFD software packages can be easily used by the 
non-specialist in the research. CFD has been used in the pharmaceutical and 
food industries, for simulation of flow in dissolution apparatus, pumps, mixers, 
spray driers, aerosol drug delivery (Chen, 2011; Kuriakose and 
Anandharamakrishnan, 2010; McCarthy et al., 2003; Pires et al., 2008; Ruzycki 
et al., 2013). However, to date, no disintegration apparatus has been 
characterised and simulated using CFD. 
1.4.4 Quality by design (QbD) 
QbD is defined by the International Conference on Harmonisation (ICH) as: “a 
systematic approach to pharmaceutical development that begins with predefined 
objectives and emphasises product and process understanding and process 
control, based on sound science and quality risk management” (ICH, 2009). 
According to QbD paradigm, quality should be built into the product by design 
and not tested into products. QbD emphasises that product and process 
understanding should be enhanced on the basis of sound scientific principles 
and design efforts to achieve predefined objectives (Awotwe-Otoo et al., 2012; 
Charoo et al., 2012; Park et al., 2013; Verma et al., 2009). Design of 
experiments (DoE), critical quality attributes, response surface methodology 
(RSM), risk assessment and process analytical technology are useful 
components of this paradigm to produce a design space (DS) for the input 
variables of the formulation (Li et al., 2013; Verma et al., 2009). FDA defined 
DS as “the multidimensional combination and interaction of input variables 
(e.g. material attributes) and process parameters that have been demonstrated to 
provide assurance of product quality” (US-FDA, 2006). According to these 
guidelines, working within the DS is allowed without further regulatory 
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approval. DoE is a useful tool to generate DS and further discussed in the 
following section, 1.4.4.1.  
1.4.4.1 DoE 
Formulation experiments can be planned to determine the effect of one variable 
at a time (OVAT), keeping all other independent variables constant. However, 
such ‘trial and error’ experiments cannot detect and quantify the interactions in 
which two or more variables act differently together compared to their separate 
effect (Del Vecchio, 1997). Also, optimised composition or process parameters 
cannot be assured by OVAT approach (Singh et al., 2011). DoE is a systematic 
approach to evaluate cause and effect relationships. This approach minimises 
the total number of experiments, simultaneously changes all factors of 
experiments and thus enables a reliable solution after the series of experiments 
(Lazic, 2004). It facilitates the conduct and planning of the experiments to 
extract maximum information with the lowest number of experiments (Vanaja 
and Rani, 2007). This tool helps in extrapolating the data, finding optimum 
formulation and process parameters and understanding the interactions.  
 
DoE methodology can be described by the following steps (Singh et al., 2011). 
a) The objective of the study must be explicitly ascertained and all input 
variables, process parameters and desired output responses are 
earmarked according to the objective.  
b) Factors or variables influencing the study are decided either by 
performing a screening process or by previous formulation experience. 
c) A suitable experimental design is selected. This selection is based upon 
the study objective, number and type of input factors or variables and 
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outcome responses. A design matrix is later generated on the basis of 
the selected experimental design. Formulations are prepared on the basis 
of the generated design matrix and the response variables are determined 
punctiliously. 
d) A suitable numerical model is proposed on the basis of the generated 
data and statistical testing. Response variables are related to the input 
variables by RSM. Response surface is the graphical presentation of the 
mathematical relationship between the input variables and outcome 
responses. 
e) The generated model is further validated by confirmatory experimental 
runs. The model can later be used to predict the input-output responses, 
effect of process parameters and possible interactions. 
 
On the basis of the above discussion, it can be concluded that the QbD paradigm 
can provide clearer understanding of the potential effects of mixing 
disintegrants and the selection of disintegrants at particular concentrations for 
arriving at the optimal RDT formulations for different disintegrant 
combinations. DoE and RSM allow the collection of data with much fewer 
experimental runs than would be possible with a traditional experimental 
design, where one variable is changed at each time. DoE in combination with 
RSM can fit linear or quadratic functions while assessing response surfaces and 
thus provide mathematical models of output responses as a function of input 
variables (Li et al., 2013). Optimal settings of these input variables can further 




The introduction chapter has provided the necessary background information 
about disintegrants and their mechanisms of action, and a review on major tablet 
disintegrants, quantification and evaluation of disintegrant action. Moreover, 
RDTs, their formulation techniques and methods to evaluate RDT disintegration 
time have also been reviewed. Lastly, experimental tools used to understand 





















2 RESEARCH GAPS AND OBJECTIVES 
2.1 Specific research gaps 
Research gaps for the current study to better understand disintegrant action and 
for evaluating RDT disintegration are summarized as follows. 
1. Many theories have been proposed for the mechanisms of disintegrant 
action but a full understanding of the disintegrant action is still deficient. 
For example, the roles of disintegrant particle deformation, strain 
recovery, heat of interaction and interruption of particle-particle bonds 
have not been conclusively studied. Also, there is no consensus on the 
major mechanism of disintegrant action for some disintegrants. 
2. The disintegration time of conventional tablets is commonly determined 
using USP disintegration apparatus. No specific pharmacopoeial 
apparatus, however, has been identified to determine the disintegration 
time of RDTs. It is often difficult to precisely determine the 
disintegration time of RDTs using USP disintegration apparatus when 
the disintegration process is very rapid. Moreover, USP disintegration 
apparatus has limitations in discriminating between disintegration times 
of different RDTs. Thus, it is necessary to develop a disintegration 
apparatus capable of precise determination of the disintegration time of 
RDTs.  
3. While many studies have investigated the use of individual 
disintegrants, little emphasis has been placed on studying potential 
synergistic effects between mixtures of disintegrants, as well as the 
possibilities of improved disintegration from mixing functionally 
different disintegrants. The interactions of the disintegrant mixtures and 
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their effects on RDT formulations have not been investigated 
extensively. Hence, it is worthwhile to understand the effects of 
disintegrant blends with different APIs in the preparation of RDTs. 
2.2 Objectives of the study  
The overall objective of this study was to understand the functionalities of 
disintegrants and evaluate RDT disintegration using novel approaches. The 
specific objectives of this study were to:  
a) elicit the functionalities of various disintegrants based on their 
mechanisms of action by visualisation using high-speed video imaging 
and by heat of interaction using solution calorimetry to develop 
qualitative and quantitative approaches in the study of major 
disintegration phenomena. 
b) develop visiometric disintegration apparatus using a combined 
computational and experimental approach for characterising RDT 
disintegration and determining short disintegration times. 
c) investigate possible synergistic behaviour of disintegrants and explore 
the relationships between compression pressure, disintegrant mixture, 
disintegration time and hardness by evaluating the DS for formulating 
RDTs by the QbD approach.  
 
The first objective described above was accomplished by studying swelling, 
wicking, velocity of particle separation upon wetting, the effect of compression 
pressure on compact disintegration, interruption of particle-particle bonds and 
heat of interaction of compacts containing different disintegrants. Swelling, 
velocity and heat of interaction parameters for free disintegrant particles in 
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contact with water were also determined. The second objective was 
accomplished by designing visiometric liquid jet mediated disintegration 
apparatus, optimising and validating their uses by CFD. The third objective was 
directed at designing RDTs with mixtures of disintegrants by direct 
compression at various compression pressures. Three APIs with different water 
solubilities were used with the disintegrant mixtures. DoE and RSM were 
employed to generate the matrix for experimentation, in which several 
components such as disintegrant mixture composition and compression pressure 
were concurrently varied and the resultant tablets analysed. Combined optimal 
design was used to elucidate the effects of disintegrants mixtures (mixture 
component) and compression pressure (numeric-process factor) on produced 
RDTs.  
2.3 Significance of the study  
A better understanding of the mechanisms of action of commonly used 
disintegrants will help in the design of disintegrating compacts which would 
possess superior performance in conventional tablets and RDTs. Determination 
of accurate RDT disintegration time will enable a precise baseline to be set for 
quality attributes of the RDT and hence assist in the design of improved RDT 
formulations. The well-engineered fast disintegrating optimal composite 
disintegrants can produce superior RDTs with optimal attributes such as 
mechanical properties and disintegration rates.  
2.4 Scope of the study 
This study focuses on the application of different approaches, i.e. high-speed 
video imaging, solution calorimetry, CFD and QbD to better understand 
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3 MATERIALS AND METHODS 
3.1 Materials 
Different materials used in the study can be classified under the categories 
called excipients, commercial RDTs, APIs and other materials.  
3.1.1 Excipients 
Various commercial grades of crospovidone, i.e. Polyplasdone XL (XPVP XL; 
ISP Technologies, Wayne, New Jersey, USA), Polyplasdone XL-10 (XPVP 
XL-10; ISP Technologies, Wayne, New Jersey, USA), Kollidon CL-SF (XPVP 
CL-SF; BASF, Ludwigshafen, Germany), commercial grades of sodium starch 
glycolate, i.e. Explotab (SSG-E; JRS Pharma, Patterson, New York, USA), 
Primojel (SSG-P; DFE Pharma, Goch, Germany), polyvinylpyrrolidone grades, 
i.e. Kollidon 30 (PVP-K30; BASF, Ludwigshafen, Germany), Kollidon 90F 
(PVP-K90; BASF, Ludwigshafen, Germany), microcrystalline cellulose (MCC; 
Avicel PH 102; FMC BioPolymer, Cork, Ireland), croscarmellose sodium 
(CCS; Ac-Di-Sol; FMC BioPolymer, Newark, Delaware, USA), pregelatinised 
starch (PGS; Starch 1500; Colorcon, West Point, Pennsylvania, USA), low 
substituted hydroxypropyl cellulose (L-HPC; Nippon Soda, Tokyo, Japan), 
mannitol (Pearlitol 400 DC; Roquette, Lestrem, France), corn starch (Purity 21; 
National Starch, Singapore), fully pregelatinised potato starch (FPGS; Prejel 
PA5 PH; DFE Pharma, Goch, Germany), hydroxypropyl cellulose (HPC-SL; 
Nippon Soda, Tokyo, Japan), polyethylene glycol (PEG-6000; Clariant SE, 
Frankfurt, Germany), dicalcium phosphate anhydrous (DCP; Chemische Fabrik 
Budenheim, Budenheim, Germany) and magnesium stearate (Mg St; Faci 
Metalest, Zaragoza, Spain)  were used in the study. All excipients were used as 
 50 
 
received and used percentage concentrations are based on w/w, unless otherwise 
stated. 
3.1.2 Commercial RDTs 
Different types of commercial RDTs used in the study are listed in Table 2. The 
tablet dimensions are the mean of 6 samples. The RDTs were all cylindrical 
tablets with either flat or bi-convex surfaces.  
Table 2. Different types of commercial RDTs used in the study 
Product Manufacturer Tablet 
Dimensions 
[d x h (mm)]* 
Mass 
(mg) 
Nimulid® - MD Panacea Biotec Ltd. 9.55 x 4.50 322.83 
Nicip MD Cipla Ltd. 9.53 x 3.70 254.33 
Tolaz - MD 5 Torrent Pharmaceuticals 
Ltd. 
5.48 x 2.93 79.50 
Voglitor MD 0.2 Torrent Pharmaceuticals 
Ltd. 
6.40 x 2.51 88.56 
Vomikind® - MD 4 Pharma Force Lab. 7.13 x 2.66 110.83 
Vomistop 10 DT Cipla Ltd. 8.10 x 2.96 179.55 
GlyprinTM UPHA Pharmaceutical 
Mfg. 
9.37 x 5.04 305.12 
*d = diameter; h = thickness 
3.1.3 APIs 
Aspirin and ascorbic acid were obtained from Chempure Pte Ltd, Singapore, 
while ibuprofen was from CFS (S) Pte Ltd, Singapore. APIs were passed 
through a 500 µm aperture size sieve before use and used percentage 
concentrations are based on w/w, unless otherwise stated. 
3.1.4 Other materials 
Glass beads (mean size, 53 µm; Pan Abrasives, Singapore), 
tris(hydroxymethyl)aminomethane (TRIS; Trizma®; Sigma-Aldrich, St. Louis, 
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Missouri, USA)  and hydrochloric acid (HCl; Schedelco, Singapore) were also 
used in the study.   
3.2 Methods 
Different methods used to investigate functionalities of disintegrants, develop 
visiometric liquid jet mediated disintegration apparatus for studying RDT 
disintegration and assess functionalities of disintegrant mixtures in RDT 
formulations are discussed in the following sections, 3.2.1, 3.2.2 and 3.2.3.  
3.2.1 Investigations on functionalities of disintegrants 
3.2.1.1 Compact preparation 
XPVP XL, MCC, CCS, PGS, SSG-E and L-HPC were used as disintegrants. 
DCP was used as an inert excipient. Glass beads were used to increase the 
contrast of the captured images. The disintegrant (70 %) was blended with glass 
beads (30 %) in a mortar with a pestle. Compacts were prepared manually by 
feeding disintegrant-glass beads mixture in a 15 mm die and compacted at 10 
mm/min and 28.3 MPa pressure (5 kN force) using a universal testing machine 
(AG-100kNE; Autograph; Shimadzu Corporation, Kyoto, Japan) at room 
temperature (25°C) and at 60 - 70 % relative humidity. Compacts of DCP (70 
%) and glass beads (30 %) were also prepared for the comparison. The thin 
compacts (0.14 ± 0.04 mm) were carefully broken into fragments between 
sheets and stored in closed containers for at least 24 h before further studies. 
This was necessary for viewing under microscope as the field of view was 
limited. All fragments used were of similar cross-sectional areas and roundish 
shape. All studies were accomplished using these compacted fragments 
containing 70 % disintegrants and 30 % glass beads. Another type of thin 
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compacts containing 90 % DCP and 10 % disintegrants were also prepared by 
the same method.   
3.2.1.2 High-speed video imaging of compact disintegration upon wetting 
Figure 13 shows the experiment setup on an optical microscope (BX61; 
Olympus Optical, Tokyo, Japan) with high-speed video camera (MotionPro HS-
3; Redlake, Tallahassee, Florida, USA) and peristaltic pump (SHD 0131; 
Watson-Marlow Limited, Falmouth, UK) to examine the disintegration 
behaviour of compacts. A fragment of the compact was placed on a microscope 
slide (25 mm x 75 mm), covered with a cover glass (24 mm x 50 mm) and 
observed under 100X magnification. Water was introduced at the side and 
allowed to flow through the compact placed between the slide and cover glass 
at a controlled delivery rate of 3 mL/min using the peristaltic pump. High-speed 
video capturing was initiated with the introduction of water and captured images 
were analysed from zero time point (time at which water just made contact with 
compact) to about 3 s. 
 
Figure 14A shows the schematic diagram of the compact before (AI) and after 
(AII) the introduction of water and images taken before (AIII) and after (AIV) 
the introduction of water. Video recording was at 100 frames per second with 
image size set at 1,024 pixels x 1,280 pixels. Images captured upon liquid 
contact to 3 s were extracted for further analysis. All compact fragments used 
were of similar cross-sectional areas and liquid introduction was controlled at 3 
mL/min. Similarity in rate of water flow was validated by measuring rate of 
water movement between microscope slide and cover glass from the video 
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images at both sides away from the compact. Video images captured and used 
for analysis were those that fulfilled above mentioned criteria.  
 
Figure 13. Schematic representation of high-speed imaging system setup along 
with optical microscope to capture compact disintegration and free particle 
















          
 
Figure 14. (A) Schematic representation of a compact before (AI) and after (AII) 
the introduction of water and images taken before (AIII) and after (AIV) the 
introduction of water, (B) Schematic representation of free particles before (BI) 
and after (BII) the introduction of water and images taken before (BIII) and after 







3.2.1.3 High-speed video imaging of the morphological and mobile changes 
of free particles upon wetting 
This study was conducted using the microscope-camera setup for studying 
compact disintegration (Figure 13) but with a stainless steel mesh (~50 μm 
aperture size) inserted between the cover glass and microscope slide instead of 
compact fragments. Free disintegrant or DCP particles were scattered on to the 
stainless steel mesh before covering with the cover glass. Water was then passed 
through the cover glass-microscope slide sandwich containing mesh and images 
of the event were captured in real-time. Figure 14B shows the schematic 
diagram of the particles before (BI) and after (BII) introduction of water. Only 
the particles which moved due to their inherent responses and not due to flow 
of the traversing waterfront were used for analysis to determine area change and 
instantaneous motion. 
 
3.2.1.4 Image analysis of compact disintegration upon wetting 
The video images were analysed to observe the disintegration behaviour of the 
compact upon contact with water till all the surface area of the compact was 
wetted, in the time frame from 0 s to 3 s. This time frame is much longer than 
the time needed for the waterfront to traverse. In addition, the velocity of liquid 
passing through the compact was determined so as to determine the capillary 
flow rate as conferred by the presence of the disintegrants. Instantaneous 
velocities of the particles separating from the compacts (compacted particles), 
in response to contact with water, were elicited to assess the disruption of 
particle-particle bonds. Disintegrability of XPVP XL, PGS and MCC 
containing compacts prepared at different compression pressures was also 
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studied to elucidate their disintegration mechanisms. Ten samples for each 
disintegrant and inert excipient were analysed to examine their capillary action 
while five samples for each disintegrant and inert excipient were used for other 
mentioned studies. 
3.2.1.4.1 Compact area measurement 
Changes in the area of compact after wetting were analysed using MATLAB 
2010a (MathWorks, Natick, Massachusetts, USA). The video footage recorded 
at 100 frames per second was assessed frame by frame in which every tenth 
frame was analysed (Figure 15A). Images were converted to grey scale followed 
by adjustment of the image intensity value (Figure 15B). Subsequent steps 
involved the creation of the morphological structuring element to perform 
morphological opening (Figure 15C). Morphological opening reduced the noise 
level in grey scale images by erosion-dilation operations. These operations were 
useful to separate the disintegrant particles from the background and thus, 
reduce the background noise. Finally, grey scale images were converted to 
binary images for area quantification (Figure 15D). Initial compact area was 
calculated at the zero time. Calculated areas obtained at subsequent time points 
were normalised by dividing by the initial area and were presented on a 
percentage scale considering initial area as 100 %. 
3.2.1.4.2 Capillary action study  
Capillary action was studied by measuring the mean time required for water to 
traverse from one end to the other of similar sized compact fragments and 
expressed as a flow rate. Capillary action was studied for both types of 
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compacts: compacts containing 70 % disintegrants (capillary action study-I) and 
10 % disintegrants (capillary action study-II). 
                                    
   
                                     
 
Figure 15. Images showing disintegration of XPVP XL compact and different 
stages of the applied image processing algorithm 
3.2.1.4.3 Compacted particle velocity measurement 
Disruption of particle-particle bonds and thus velocity profile of the compacted 
particles was obtained using PIV program of MATLAB R2010a. As discussed 
earlier, PIV requires sequential images of the flow field and these images are 
divided into sub-images. The detection sub-image size was adjusted as 64 pixels 
x 64 pixels and the overlapping ratio of adjacent sub-image was kept as 0.5. In 
the initial 0.5 s, the velocity vectors obtained comprised vectors due to the initial 
burst movements of compacted particles as well as some water movement but 
(A) Image capturing (B) Grey scaling 
(C) Morphological opening (D) Thresholding 
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most of the vectors generated in the subsequent 2.5 s could be attributed to the 
compacted particles. Average velocities of all generated vectors from first and 
next analysed images were calculated and the same routine was repeated for 
subsequent images to determine the average velocity profile in the 3 s 
measurement time frame. Velocity-time profiles of all materials were integrated 
for their respective distance-time profiles. For comparison, distance-time 
profiles of all compacts containing disintegrants were compared against the 
baseline distance-time profile of the control, an inert excipient, DCP. 
3.2.1.4.4 Effect of compression pressure on compact disintegration 
Compacts of XPVP XL, MCC and PGS were prepared over a range of 28.3 MPa 
to 169.8 MPa compression pressure (section 3.2.1.1) and changes in the area of 
these compacts after wetting were analysed (section 3.2.1.4.1) to study the effect 
of compression pressure on disintegration.    
3.2.1.5 Image analysis of morphological and mobile changes of free 
particles upon wetting 
Changes in the area of free particles (disintegrant and DCP) were also 
determined using image capture and analysis system (Image Pro Plus; Media 
Cybernetics, Bethesda, Maryland, USA). Instantaneous velocity of the free 
particle on contact with water was analysed using image tracking software 
(Track Eye Motion Analysis; TEMA 2.6; Image Systems AB, Linkoping, 
Sweden). Velocity-time profiles of free particles of each material were 
integrated to obtain their respective distance-time profiles. 
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3.2.1.6 Solution calorimetry data measurement 
The enthalpy of interaction was determined at 25°C using a solution calorimeter 
(Parr 6755; Parr Instrument Company, Moline, Illinois, USA). The solution 
calorimeter was calibrated using 0.5 g TRIS (reference standard) and 100 g 0.1 
N HCl and later used to determine the enthalpy changes of samples. XPVP XL, 
MCC, CCS, PGS, SSG-E, L-HPC SSG-P, mannitol, corn starch, FPGS, HPC-
SL, XPVP XL-10, XPVP CL-SF, PVP-K30, PVP-K90 and PEG-6000 were 
used in the study. The samples were equilibrated in a desiccator prior to use in 
the experiments.  
 
In the measurement procedure, the dewar flask was first filled with the test 
liquid medium and placed in the solution calorimeter. Sample was loaded into 
the cell assembly which was then attached to the stirring shaft. Sample was 
released and mixed with the liquid medium after thermal equilibrium. The 
thermogram of the sample run was generated and the change in enthalpy 
calculated. 
3.2.1.7 Enthalpy calculations 
The known energy input was calculated first for TRIS using the following 
equation. 
QE = mref*[58.738 + 0.3433*(25-T(0.63R))] (Equation 4) 
where QE is the energy input (calories), mref is the weight of TRIS (g) and 
T(0.63R) is the temperature at a point on the thermogram when the temperature 




In the next step, energy equivalent of the calorimeter, e, (calories/°C) was 
calculated using the following equation, 
e = QE/ΔTc-ref  (Equation 5) 
where ΔTc-ref is the net corrected temperature rise due to TRIS and 0.1 N HCl 
interaction (°C). 
 
Next, the energy change in the system, Q, was calculated using the following 
equation 
Q = (ΔTc)*(e) (Equation 6) 
where ΔTc is the net corrected temperature rise due to the sample-solvent 
interaction (°C) and e is the energy equivalent (calories/°C). 
 
The change in the enthalpy, ΔH, was calculated by the following equation, 
ΔH = (-Q)/m (Equation 7) 
where m is the mass of the sample used (g) 
3.2.2 Development of visiometric liquid jet mediated disintegration 
apparatus for studying RDT disintegration 
Two final designs of visiometric liquid jet mediated disintegration apparatus 
were fabricated for studying RDT disintegration. The term visiometric is used 
to describe the process of capturing the images of in-process condition (visio) 
and extracting the measurements (metric) from the captured images at different 
time points. Liquid jets were used to deliver the disintegration medium and so 
included in this nomenclature. Henceforth, these two designs would be referred 
as disintegration apparatus-I and disintegration apparatus-II.  
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3.2.2.1 Disintegration apparatus-I 
Three design versions of RDT disintegration compartment (part of 
disintegration apparatus-I, Figure 16) with progressive modifications were 
prepared and simulated using CFD software packages, GAMBIT 2.4.6 (Ansys, 
Canonsburg, Pennsylvania, USA) and FLUENT 6.3.26 (Ansys, Canonsburg, 
Pennsylvania, USA).  The prototype was assigned as design A, improved 
version as design B and accepted version as design C. These compartments 
would be the sites, where disintegration medium would come in contact with 
the RDTs and enable complete disintegration. Thus, compartment designs are 
very important for providing an assembly sensitive to short disintegration times 
as required in this disintegration study.  
3.2.2.1.1 CFD simulation study 
CFD software packages GAMBIT 2.4.6 and FLUENT 6.3.26 were used to 
derive a numerical solution to the equations governing the fluid flow inside the 
defined flow geometry at different stages of the apparatus design. These 
equations were considered as mathematical formulations based on the 
conservation laws of fluid dynamics.  Each continuous fluid flow problem was 
discretised with a grid or mesh to define the flow variables at the grid points and 
the governing equations of fluid flow were solved for each volume at the 
vicinity of the grid. 
3.2.2.1.1.1 Geometrical models and grid generation of RDT disintegration 
compartment in GAMBIT - Preprocessor 
Dimensional wireframe geometries for each of the disintegration compartment 
designs were generated using preprocessor, GAMBIT 2.4.6. The computational 
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domain of each geometry encompassed internal chamber, external chamber, 
inlet tubes and outlet tubes. 
 
Figure 16. Designs of the simulated and fabricated disintegration compartment 
cells of the disintegration apparatus-I 
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The geometry was preprocessed and meshed using tetrahedral/hybrid elements, 
Tgrid type and 0.5 spacing.  The final meshes contained ~ 60000 nodes and 
~290000 cells for each design. Mesh quality was monitored using equal angle 
skewness parameter of GAMBIT. The best value of this parameter is 0 whereas 
the worst is 1 and the acceptable value is less than 0.9 (Son et al., 2011). Nearly 
91 % elements were active in the range of 0 - 0.5 and all elements were active 
in the range of 0 - 0.75 in each design which indicated an acceptable mesh 
quality. Different boundary types, e.g. velocity inlet, interior and wall, were 
specified for relevant faces of the geometry. Finally, the generated mesh files of 
all the designs were exported to finite volume based CFD solver, FLUENT 
6.3.26.  
3.2.2.1.1.2 Solution of the governing integral equations using FLUENT - 
Solver 
The governing equations of mass and momentum were numerically solved 
using FLUENT. Grid of each imported file was first checked and scaled. Model 
(3D, pressure based and laminar), physical properties (density and viscosity of 
water), operating condition (pressure) and boundary conditions (inlet and outlet 
velocities) of the problem were defined in FLUENT. Since the 3D environment 
involves 3 momentum equations and 1 continuity equation, 4 residuals of error 
were required to monitor convergence, the stage at which the solution was 
expected to be achieved or arrived. Convergence criteria of 1e-3 were set for all 
4 equations by which the error of the solution was minimised. The solution was 
initialised and the calculations iterated until the simulation converged. Figure 
17  shows the convergence curves for all three RDT disintegration compartment 
designs, indicating that the algorithms used were feasible. Data file was saved 
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after calculation and post-processing was performed to visualise the findings. 
Velocity magnitude and total pressure contour plots were generated in the post-
processing step and analysed to determine the best design of the apparatus. The 
findings were then compared with actual experimental results. 
 
Figure 17. Convergence curves of the disintegration compartment (A) design 
A, (B) design B and (C) design C 
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3.2.2.1.2 Fabrication of the disintegration apparatus-I 
The disintegration apparatus-I for RDT comprised two distinct components, a 
disintegration compartment and a measurement device. 
 
The disintegration compartment, representing each design built sequentially, 
was simulated in CFD. The disintegration compartment was fabricated with two 
concentric acrylic chambers. The diameter and height of the internal chamber 
were 16 mm and 6 mm respectively (Figure 16). Three hollow metal tubes 
(internal diameter 1.8 mm) were inserted at 1.5 mm above the base angularly 
into the internal chamber. Disintegration medium was introduced via these 3 
tubes (inlets) into the internal chamber using a programmable syringe pump 
(NE-1600; New Era Pump Systems, Farmingdale, New York, USA) with a 
swirling flow of medium in the chamber. The swirling liquid flow was designed 
to create the requisite shear stress on the disintegrating RDT and thus, to mimic 
the mechanical stress applied by mastication action of the tongue on the RDT. 
Flow rates of disintegration medium could easily be adjusted by the 
programmable syringe pump; even allowing adjustment of different flow rates 
at different time intervals. The function of the external chamber was essentially 
to drain excess disintegration medium as well as disintegrated tablet fragments 
from the internal chamber by an overflow mechanism. The swirling liquid flow 
also aided the removal of heavier fragments from the internal chamber by 
centrifugal forces. Three larger hollow metal tubes (outlets) were attached to 
the external chamber to remove the content of the external chamber.  The 
chambers were tightly sealed with a transparent cover over the taller external 
chamber, aided by holding screws. 
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The measurement device consisted of a video camera (MotionPro HS-3; 
Redlake, Tallahassee, Florida, USA), a stereomicroscope (SZ61; Olympus 
Optical Co. Ltd, Tokyo, Japan), a base light source and a computer for data 
acquisition. The camera was mounted on the stereomicroscope such that the top 
surface of the RDT in the disintegration compartment could be seen clearly on 
the computer screen. A schematic view of the disintegration apparatus setup is 
shown in Figure 18.  
 
 
Figure 18. Schematic view of the visiometric liquid jet mediated disintegration 












   










3.2.2.1.3 RDT disintegration time measurement 
Commercial RDTs were randomly inscribed by roman numerals (i to vi) and 
thus the identity of RDT was concealed during the experiment. Six samples of 
each type of RDTs were used for each experiment. RDT was first placed in the 
internal chamber which was then sealed to prevent leakage of the disintegration 
medium (water). Next, the medium was introduced at 23 mL/min by the 
programmable pump into the internal chamber resulting in a gradual rise in the 
level of medium inside the chamber. The high flow rate ensured filling of the 
internal chamber within 1 s. Once the internal chamber was completely filled, 
excess medium drained along with the disintegrated fragments into the external 
chamber and was removed by the peristaltic pump. The disintegration action 
was captured by real-time video imaging. Video recording was at 30 frames per 
second, with image size set at 1024 pixels x 1280 pixels. The disintegration 
process was observed under 3.75X magnification.  The disintegration end point 
was determined from the video images when none of the disintegrated RDT 
fragments remained in the internal chamber except occasional residues of 
settled deaggregated particles at the bottom of the chamber. The shear stress 
applied to an RDT by the tongue is low. Hence, in testing of such dosage forms, 
a minimal flow rate, which results in the corresponding requisite shear stress, is 
desired. Disintegration medium was pumped at 23 mL/min because this was the 
minimal flow rate found at which necessary shear stress was delivered to the 
disintegrating dosage form and disintegrated particles were easily removed 
from the internal chamber to the external chamber. Lower flow rates were not 
effective in removing the disintegrated particles from the chamber. 
Disintegration time of RDT was also determined using the conventional USP 
 68 
 
disintegration apparatus by introducing the RDT into the tube of a disintegration 
apparatus along with a disk when the tube was at its highest point. Upon 
introduction of RDT, timing was initiated. Disintegration time was noted 
visually when either no residue remained on the screen of the test apparatus or 
the residue which remained on the screen of the test apparatus was a soft mass 
having no firm core. 
3.2.2.2 Disintegration apparatus-II 
On the basis of results obtained using the disintegration apparatus-I and 
experimental observations, the design of the disintegration compartment was 
improved, resulting in the development of disintegration apparatus-II which was 
employed for further studies on RDT disintegration. The measurement 
methodology was similar as for the fabricated disintegration apparatus-I 
(section 3.2.2.1.3). Details on the re-designed apparatus are given below. 
3.2.2.2.1 Fabrication of disintegration apparatus-II 
The disintegration apparatus-II for RDT comprised two distinct components, a 
disintegration compartment and a measurement device. 
  
The disintegration compartment (Figure 19) included a cylindrical cell, with 
dimensions of 16 mm in diameter and 10 mm in depth for seating the RDT. Two 
disintegration medium inlets at opposite sites were used to deliver the 
disintegration medium into the cylindrical cell where the disintegration medium 
comes in contact with RDT and disintegration of the RDT is effected. Low 
settings of both inlets, at the same level as the base of a cylindrical cell were 




Figure 19. Perspective view of fabricated disintegration compartment of 
disintegration apparatus-II 
 
Figure 20. Side views of different possible disintegration medium inlet shapes 
to deliver disintegration medium with shear swirling action for its intended 
purpose 
Inlets with these shapes could provide the required swirling action of the 
disintegration medium onto the disintegrating tablet as well as to allow rapid 
and sufficient wetting at the lower surface of the tablet, both of which were 
required to completely remove the disintegrated tablet fragments from the 
disintegration cell. L shaped disintegration medium inlets were chosen for this 
study. The disintegrated tablet fragments along with disintegration medium 
were removed from the disintegration compartment and if needed, via a 
retention mesh of aperture size 2 mm, towards the outlet. The disintegration 
Disintegration medium inlet 1 
Retention mesh (optional) 
Outlet 




compartment design was also simulated by CFD software packages using a 
similar method described in section 3.2.2.1.1. Again, the purpose for CFD 
simulation was to study the flow properties of the disintegration medium. 
 
The measurement device is as described under section 3.2.2.1.2. A video camera 
mounted upon a stereomicroscope was used to capture the disintegration 
process and a computer was used as the data acquisition system to store the 
transferred images. Light is applied from the transparent base for a clearer view 
of the disintegration process. The same schematic view depicted in Figure 18 
can be considered for this disintegration apparatus. Glass, plastic, metal or a 
combination of materials can be used to construct the apparatus. The flat bottom 
surface of the apparatus must be made of a transparent material to allow the 
passing of light from a base light source through the cell for visualisation of the 
tablet within. Alternatively, a reflecting system may be used with top lighting, 
with a mirror-surfaced base. 
3.2.2.2.2 RDT disintegration time measurement 
RDT was placed into the disintegration compartment. The disintegration 
medium was delivered into the disintegration compartment through the liquid 
jet inlets from opposite ends. A liquid syringe pump was used to deliver the 
disintegration medium. Tablet disintegration or break-up into fragments was 
effected when contact is made with disintegration medium. The disintegration 
process was captured in real-time using a video camera. The disintegration 
medium along with disintegrated tablet fragments was washed away from the 
disintegration cell by the overflowing liquid. The end point of the disintegration 
process was considered to be when no large fragments were present in the 
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disintegration cell or when occasional residues of disintegrated mass settled on 
the base, wall or mesh of the disintegration cell and became immobilised. The 
disintegration process was documented by the real-time video images. The 
disintegration time of RDT was also performed using USP disintegration 
apparatus by the method as described in section 3.2.2.1.3.    
 
Disintegration time of 7 different types of RDTs (6 different types of 
commercial RDTs and 1 laboratory prepared placebo RDT) were measured in 
first phase of the study. RDTs were randomly inscribed by alphabets (a to g) 
and thus the identity of RDT was concealed during the experiment. To prepare 
placebo RDT, Mannitol (89.5 %) and XPVP CL-SF (10 %) were manually 
mixed in a polyethylene bag for 8 min. Mg St was added to the mixture and 
further blended for 2 min. The blend was compressed at 88.7 MPa compression 
pressure using 8 mm flat-faced punches in a manual press (Natoli Engineering 
Company, Saint Charles, Missouri, USA).   
 
In second phase, the suitability of disintegration apparatus-II for RDT 
disintegration testing was further confirmed by evaluating the disintegration 
times of 117 laboratory prepared RDT formulations which had disintegration 
times < 3 min as determined using USP disintegration apparatus by the method 
described in section 3.2.3.3. The general compositions and methodology used 
for these formulations are described in sections 3.2.3.1 and 3.2.3.2.   
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3.2.3 Assessment of functionalities of disintegrant mixtures in RDT 
formulations by a QbD approach 
3.2.3.1 Experimental Design 
A combined optimal design was crafted using Design-Expert 8.0.7.1 
(Minneapolis, Minnesota, USA), comprising 5 mixture components (CCS, 
XPVP CL-SF, SSG-P, MCC and mannitol) and 1 numeric factor (compression 
pressure). The 5 mixture components were each set to range from 0 - 10 % of 
the tablet composition, with the total sum of the 5 components being 10 % of 
the tablet composition. The API used comprised 50 % of the composition and 
Mg St was used at 0.5 %. Mannitol was also used as filler in the remaining 
fraction of the total composition. Compression pressure was set as a discrete 
variable with 4 levels (88.7, 177.3, 266 and 354.7 MPa). An IV-optimal, 
reduced quadratic x quadratic model was selected. IV optimality is desirable for 
RSM where prediction is important. The algorithm picks points that minimise 
the integral of the prediction variance across the DS. The experiment was 
designed as 1 block. A total of 55 runs was generated, and the runs were 
randomised to avoid systematic error (Table 3). A set of 55 runs was prepared 
for each API (aspirin, ascorbic acid and ibuprofen). Tablets prepared were tested 
for disintegration time and hardness. 
3.2.3.2 Preparation of tablets 
Mannitol, API and disintegrants (CCS, XPVP CL-SF, SSG-P and MCC) were 
weighed out and manually mixed in a polyethylene bag for 8 min. Mg St was 
added to the mixture and further blended for 2 min.  The blend was compressed 
using 8 mm flat-faced punches in a manual press. Compression pressures used 
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were as determined by the RSM. A total of twenty tablets (each weighing 200 
mg) were compressed per run and tablets were stored for at least a week before 
testing. 



















1 0 4.39 5.61 0 0 50 0.5 354.7 
2 4.55 0 5.45 0 0 50 0.5 266 
3 4.91 0 0 5.09 0 50 0.5 266 
4 0 0.27 4.69 5.03 0 50 0.5 266 
5 1.29 0.33 1.95 4.4 2.04 50 0.5 88.7 
6 0 10 0 0 0 50 0.5 88.7 
7 0 4.93 5.07 0 0 50 0.5 88.7 
8 0 5.01 0 4.99 0 50 0.5 177.3 
9 4.75 5.25 0 0 0 50 0.5 177.3 
10 0 10 0 0 0 50 0.5 266 
11 0 0 0 5 5 50 0.5 177.3 
12 0 0 0 0 10 50 0.5 266 
13 0 5.23 4.77 0 0 50 0.5 266 
14 5.6 0 1.04 0 3.36 50 0.5 266 
15 0 0 0 4.9 5.1 50 0.5 88.7 
16 0 4.9 0 0 5.1 50 0.5 354.7 
17 0 0 0 0 10 50 0.5 88.7 
18 0 0 0 10 0 50 0.5 88.7 
19 5.38 0 4.62 0 0 50 0.5 354.7 
20 0 0 0 0 10 50 0.5 177.3 
21 0 0 4.92 5.08 0 50 0.5 88.7 
22 0 4.91 0 0 5.09 50 0.5 266 
23 0 0 0 5.08 4.92 50 0.5 354.7 
24 10 0 0 0 0 50 0.5 177.3 
25 4.85 5.15 0 0 0 50 0.5 88.7 
26 0 5.23 4.77 0 0 50 0.5 266 
27 0 0 5.06 4.94 0 50 0.5 354.7 
28 10 0 0 0 0 50 0.5 354.7 
29 0 0 10 0 0 50 0.5 354.7 
30 0 0 0 5 5 50 0.5 177.3 
31 0 0 0 10 0 50 0.5 266 
32 0 5.01 0 4.99 0 50 0.5 177.3 
33 5.07 0 0 0 4.93 50 0.5 354.7 
34 5.04 0 0 0 4.96 50 0.5 177.3 





















36 0 0 10 0 0 50 0.5 88.7 
37 0 0 10 0 0 50 0.5 266 
38 0 5.1 0 0 4.9 50 0.5 88.7 
39 0 0 5 0 5 50 0.5 88.7 
40 0 0 0 10 0 50 0.5 354.7 
41 4.9 0 0 5.1 0 50 0.5 354.7 
42 5.1 0 0 4.9 0 50 0.5 88.7 
43 0 0 5.08 0 4.92 50 0.5 354.7 
44 0 0 4.98 0 5.02 50 0.5 177.3 
45 0 0 0 0 10 50 0.5 354.7 
46 0 4.97 0 5.03 0 50 0.5 354.7 
47 5.2 0 0.81 3.99 0 50 0.5 177.3 
48 10 0 0 0 0 50 0.5 88.7 
49 0 0 5.08 4.92 0 50 0.5 177.3 
50 5.01 0 4.99 0 0 50 0.5 88.7 
51 0 4.91 0 0 5.09 50 0.5 266 
52 4.75 5.25 0 0 0 50 0.5 177.3 
53 0 5.08 0 4.92 0 50 0.5 88.7 
54 0 10 0 0 0 50 0.5 354.7 
55 5.09 0 0 0 4.91 50 0.5 88.7 
*Compression pressure 
 
3.2.3.3 Disintegration test 
According to the experimental matrix, some tablets were designed not to have 
sufficient disintegrant amounts and thus were not expected to disintegrate 
within 3 min (the suggested disintegration time of RDTs by European 
Pharmacopoeia). Therefore, the fabricated disintegration apparatus-II 
(particularly suitable for RDT) was not used in this experimental study and 
disintegration of tablets was performed using the USP disintegration apparatus, 
without disks, in water at 34°C (to simulate temperatures on the tongue). 
Disintegration times of 6 tablets per batch were determined and the mean values 
of the various test formulations were entered into Design-Expert. 
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3.2.3.4 Hardness test 
Hardness was determined using a hardness tester (Copley TBF 1000, 
Nottingham, UK). The hardness values for 6 tablets per batch were determined 
and the mean value was entered into Design-Expert.  
3.2.3.5 Statistical analysis 
3.2.3.5.1 Generation of disintegration time and hardness models for APIs 
Models were generated by Design-Expert to describe possible relationships 
between mixture components and compression pressures. Analysis of variance 
(ANOVA) was carried out for each model. R2, p-value, lack of fit and Adeq 
precision values were checked and the best model was selected. “Adeq 
precision” measures signal to noise ratio. The value should be greater than 4 to 
indicate an adequate signal and imply that the model can be used to navigate the 
DS. Backward elimination regression was used to remove insignificant terms 
(p>0.05). 
3.2.3.5.2 Validation of selected models 
Validation of the selected model and optimisation was determined by 
experimental confirmation of predicted disintegration time and hardness of 
numerically optimised solutions. Three numerically optimised formulations for 
each API were chosen for validation (Table 4). Numerical optimisation criteria 
were the minimization of disintegrant composition and minimization of 
predicted disintegration time. The target hardness for tablets was at least 20 N. 
New batches of RDTs with predicted values of input variables were prepared 
and output responses measured to confirm the validity of generated models. 
  
 



















1 44.1 0 0 0.3 5.1 50.0 0.5 354.7 
2 44.2 0 0 0 5.3 50.0 0.5 354.7 
3 41.2 2.3 0 0 6.0 50.0 0.5 266 
Ascorbic acid 
1 44.6 0 0 4.0 0.8 50.0 0.5 354.7 
2 42.5 1.4 2.9 2.7 0 50.0 0.5 177.3 
3 43.9 1.3 0 3.4 0.8 50.0 0.5 266 
Ibuprofen 
1 43.7 0 1.7 0 4.1 50.0 0.5 88.7 
2 42.9 0 2.2 1.2 3.3 50.0 0.5 88.7 
3 39.5 2.5 2.5 2.5 2.5 50.0 0.5 88.7 






3.2.3.5.3 Graphical optimisation analysis using validated models 
The optimised regions within the DS were further identified based on the 
desired criteria of output responses. Graphical optimisation option was used for 
this purpose and an overlay plot was generated to depict the effect of input 
variables on output responses. Output response limits were required to specify 
for overlay plot generation. Limits specified in the software were: disintegration 




































4 RESULTS AND DISCUSSION 
4.1 Investigation on functionalities of disintegrants 
High-speed video imaging and solution calorimetry were used to investigate 
functionalities of disintegrants. Results obtained in the study are further 
discussed in the following sections.  
4.1.1 Compact area and free particle area measurements  
The increase in the total disintegration area of the compact upon wetting was 
measured over the first 3 s (Figure 21A). The trend observed in cross-sectional 
area increase for the various compacts was as follows: SSG-E > CCS > PGS > 
XPVP XL > MCC > L-HPC > DCP. Similarly, increase in the area of free 
particle was also obtained during the first 3 s after wetting (Figure 21B). As for 
the compacts containing SSG-E, the free SSG-E particles showed highest mean 
increase in swollen area at 3 s followed by CCS and other disintegrants but 
XPVP XL showed very little increase in cross-sectional area, almost 
comparable with the inert DCP. It was understandable that the relative change 
in the area for compact was less in comparison with free particle because 
deformation of the compact would limit the potential area increase. Among the 
disintegrants studied, only XPVP XL acted differently, showing greater change 
in the area after compaction (Figure 22). The findings indicated that intrinsic 
particle swelling, as seen for starch-based excipients, was not a major 
mechanism for XPVP XL compact disintegration. It can be envisaged from 
Figure 22 that most disintegrants swelled relatively less after compaction, with 





Figure 21. Percent area covered at different time points by (A) compacts and 
(B) free particles upon wetting,  SSG-E (○), CCS (●), XPVP XL (□), PGS (■), 
MCC (Δ), L-HPC (▲), DCP (▽) (results are the mean and standard deviation 
of five determinations) 










































Figure 22. Ratio of the area change of compacts and free particles, SSG-E (○), 
CCS (●), XPVP XL (□), PGS (■), MCC (Δ), L-HPC (▲) (results are the ratio 
of mean area change of five determinations) 
4.1.2 Capillary action study-I 
For tablet disintegration, the establishment of contact with water for disintegrant 
particles is essential. Thus, the flow rate of water through the compact 
containing disintegrant is a measure to directly correlate with the capillary 
action of the disintegrant. Among the disintegrants and inert excipient (DCP) 
studied, flow rate of water through the compact decreased in the following 
order: MCC > SSG-E > PGS > DCP > L-HPC > CCS > XPVP XL (Figure 23). 
XPVP XL clearly promoted less capillary action than the starch-based 
disintegrants. MCC demonstrated the best capillary action, suggesting its 
superior wicking property. However, for XPVP XL, good wicking action was 
not a pronounced effect. 






























Figure 23. Capillary action study of compacts containing different disintegrants 
and an inert excipient, DCP (results are the mean and standard deviation of ten 
determinations) 
4.1.3 Compacted and free particle velocity measurement upon wetting 
4.1.3.1 Compacted particle velocity 
Velocity-time profiles of compacted particles were generated using the PIV 
technique. Figure 24 shows typical plots of velocity fluctuations over 3 s after 
wetting for compacts containing XPVP XL and DCP. The profiles were 
integrated to generate distances travelled over time for all the disintegrants 
studied and DCP (Figure 25). Total distance moved in 3 s was highest for CCS 




























Figure 24. Velocity fluctuations of compacted (A) XPVP XL and (B) DCP 
(results are the mean and standard deviation of five determinations) 











































Figure 25. Distance travelled by compacted particles upon wetting, SSG-E (○), 
CCS (●), XPVP XL (□), PGS (■), MCC (Δ), L-HPC (▲), DCP (▽) (results are 
the mean and standard deviation of five determinations) 
4.1.3.2 Free particle velocity 
Velocity and distance travelled profiles of free particles were also studied. 
Figure 26 and Figure 27 illustrate typical plots of velocity fluctuations over 3 s 
after wetting for free disintegrant particles XPVP XL, DCP and CCS, and 
distances travelled over time for all disintegrants studied, respectively. 
Correlation was found for the mobility of free particles and compacts when 
wetted for CCS, SSG-E, PGS and L-HPC. On the other hand, compacts of 
XPVP XL showed significantly higher mobility than free XPVP XL particles. 
These findings suggested that the application of compression pressure on XPVP 
XL had altered its sensitivity to water and possibly contributed to compact 
disintegration. This experiment provided evidence that the disintegration action 
of XPVP XL is due to recovery of energy of compaction induced strain 
deformation. 






















Figure 26. Velocity fluctuations of free (A) XPVP XL, (B) DCP and (C) CCS 
(results are the mean and standard deviation of five determinations) 





























































Figure 27. Distance travelled by free particles upon wetting, SSG-E (○), CCS 
(●), XPVP XL (□), PGS (■), MCC (Δ), L-HPC (▲), DCP (▽) (results are the 
mean and standard deviation of five determinations) 
4.1.4 Effect of compression pressure on disintegration 
Results obtained suggested the importance of strain recovery as the major 
mechanism of XPVP XL disintegration action along with other complementary 
mechanisms. Further studies were carried out by preparing XPVP XL compacts 
at different compression pressures (forces) [28.3 MPa (5 kN); 84.9 MPa (15 
kN); 113.2 MPa (20 kN); 141.5 MPa (25 kN) and 169.8 MPa (30 kN)] and 
changes in compact area on contact with water were determined. Compacts 
containing PGS and MCC were also prepared for comparative studies. It has 
been widely accepted that starch-based disintegrants have high swelling 
efficiency along with capillary action and MCC shows prominent capillary 
action. Results obtained for compacts prepared at different compression 
pressures showed that the disintegration behaviour was not significantly 
different for the compacts containing XPVP XL when compacted at 28.3 MPa 
or 84.9 MPa, but increased thereafter and remained constant up to the 169.8 
MPa, the upper limit of compression pressure used in the study (Figure 28A and 


















Figure 29). On the other hand, area change for compacts containing PGS 
compacts prepared at 28.3 MPa and 84.9 MPa compression pressures were 
unchanged but significantly decreased thereafter for compression pressures of 
113.2 MPa to 169.8 MPa (Figure 28B and Figure 29). In contrast, area change 
of MCC containing compacts were largely unchanged albeit decreased slightly 
at each stage with increase in compression pressures from 28.3 MPa to 169.8 
MPa (Figure 28C and Figure 29). 
 
Compaction by the use of compression pressures within the normal range for 
tablet preparation affects capillary action by two mechanisms. Firstly, the 
diameters of capillary microstructures in compacts would have been reduced 
with increased compression pressure. This may contribute favourably to 
increase the rate of liquid entry at lower compression pressures according to 
Washburn’s equation (De Schoenmaker et al., 2011). Secondly, compaction 
could also reduce the overall microstructure volume or porosity. This can 
adversely limit the extent of liquid entry into compacts. Therefore, 
disintegration rate could effectively be lowered by the increase in compression 
pressure for wicking disintegrants. However, increase in compression pressure 
had increased the disintegration rate for XPVP XL compacts. Here, expansive 
pressure contributed by disintegrant particles upon strain recovery to regain 
their initial state upon wetting could be a major reason for XPVP XL 
disintegrant action and not wicking. Linear algebraic equation was applied to 
model PGS disintegration during the first 3 s. Decrease in disintegration rate 
was observed with increase in compression pressure. This linear model could 






Figure 28. Effect of compression pressure on (A) XPVP XL, (B) PGS and (C) 
MCC disintegration, 28.3 MPa (○), 84.9 MPa (●), 113.2 MPa (□), 141.5 MPa 
(■), 169.8 MPa (Δ) (results are the mean and standard deviation of five 
determinations) 


































Figure 29. Comparison of the effect of compression pressure on compact 
disintegration at 3 s, XPVP XL (□), PGS (■), MCC (Δ) (results are the mean 
and standard deviation of five determinations) 
time required to wet all the starch particles would be longer for compacts 
prepared at a higher compression pressure due to restricted liquid entry. 
Therefore, swelling pressure brought about by the starch particles was 
restrained by reduced volume of liquid entry and disintegration was hence 
delayed, resulting in linear decrease in disintegration rate. Also, the findings 
suggested that functionality of swelling disintegrants was not necessarily 
enhanced with compression pressure. 
 
Disintegration of MCC compacts in the initial 0.3 s after wetting was 
mathematically modelled. Disintegration rate was exponential for the compacts 
prepared at 28.3 MPa and 84.9 MPa compression pressure but changed to linear 
with further increase in pressure. This trend could be due to the change in water 
penetration rate in the porous network of MCC compacts. It has been reported 
that increase in compression pressure decreases the small mesopore size (~5 - 
20 nm) of MCC compacts to a larger extent than high macropore size (above 50 




















could be severely reduced with increase in compact density where it may not 
form continuous microstructures throughout the compact. Thus, increase in 
compression pressure decreased porosity and ease of water mobility, resulting 
in a linearly driven disintegration rate. The finding implies that capillary action 
into the compact is the rate limiting factor for MCC compact disintegration. 
4.1.5 Capillary action study-II 
In the previous studies, the compacted fragments contained a relatively high 
proportion of disintegrants (70 %). Capillary action study was also performed 
using compacts containing a reduced proportion of disintegrants (10 %). Among 
the disintegrants studied, flow rates of water through the compacts decreased in 
the following order: PGS > MCC > SSG-E > L-HPC > CCS > XPVP XL (Figure 
30).  
 
Figure 30. Capillary action study of compacts containing different disintegrants 
(10 %) and an inert excipient, DCP (90 %) (results are the mean and standard 























Again, XPVP XL was found to have the lowest flow rate and thus much less 
capillary action than the cellulose and starch-based disintegrants. This study 
affirmed the previous findings and demonstrated that the disintegrants also 
functioned in a similar way when employed in much reduced proportions 
(similar to the amounts used in actual tablet formulations). 
4.1.6 Solution calorimetry study 
Figure 31 shows the change in enthalpy (ΔH) values for free disintegrant 
particles and other excipients. All disintegrants produced negative ΔH values, 
thus all disintegrants showed exothermic properties. Disintegrants (or other 
excipients with similar structures) could be classified according to ΔH values 
into 3 major groups by their origins: a) Natural starch and cellulose excipients, 
b) modified starch and cellulose excipients, and c) synthetic excipients. Starch 
and cellulose-based natural disintegrants (corn starch and MCC) have the lowest 
exothermic values. Exothermic values increased further for modified starches 
(SSG-E and SSG-P). Even higher exothermic values were obtained with 
modified celluloses (L-HPC, HPC-SL and CCS). Exothermic properties of 
starch increased after pregelatinisation. The trend observed for exothermic 
values for natural and pregelatinised starches was as follows: FPGS > PGS > 
Corn starch. Synthetic excipients, XPVP XL, XPVP XL-10, XPVP CL-SF, 
PVP-K30 and PVP-K90 had the highest exothermic properties. Among the 
diluents investigated, DCP showed a small exothermic response but mannitol 
had considerable endothermic properties upon interaction with water. Polymer 
chain length, molecular weight and structure should also exert some effects on 
the ΔH values of the polymers. For example, higher exothermic values were 




























length and higher molecular weight of PVP-K90 could be the reason for this 
observation. Also, coiled chains of PEG-6000 did not produce any significant 
ΔH in comparison with PVP-K30 and PVP-K90. The coiled structure of PEG 
could be responsible for the insignificant endothermic property of this polymer. 
Exothermic values were enhanced after compaction for different crospovidone 
grades, corn starch and MCC (Figure 32). On the other hand, exothermic values 
were reduced after compaction for CCS and, marginally, for SSG-E and SSG-
P (Figure 33). 
 
Figure 32. ΔH values of different crospovidone grades, MCC and corn starch 
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4.1.7 Understanding disintegrant action by visualisation 
It has been suggested that the mechanisms of tablet disintegration could be 
identified by a plot of compression pressure against disintegration time (Fassihi, 
1986). By this assumption, disintegrants which act primarily by swelling and 
wicking would show a decrease in disintegrability with an increase in 
compression pressure. XPVP XL showed increased disintegrability with 
increase in compression pressure, thus indicating that swelling and wicking 
could not be its major mechanism of disintegration. The reason for the swelling 
of compacts containing crospovidone has also been explained by some 
researchers (Zhao and Augsburger, 2005a). It was pointed out that, free 
crospovidone particles did not have any significant inherent swelling property 
but tablets containing crospovidone appeared to swell conspicuously. It was 
thus concluded that crospovidone had a high compaction induced deformation 
capacity and the rapid swelling upon wetting was attributed to the recovery of 
this deformation (Zhao and Augsburger, 2005a). The extent of hydration and 
swelling depends on the accessibility of the hydroxyl groups in the starch and 
cellulose-based disintegrants (Khan and Pilpel, 1987; Khan et al., 1988; 
Newman et al., 1996). Hydration causes the polymer strands in the film to 
stretch out and swell. Absence of free hydroxyl groups and low water binding 
capacity in contrast to cellulose suggested the unlikely possibility for swelling 
by crospovidone physicochemically (Jain et al., 2010). It was also reported that 
crospovidone compacts absorbed liquid (0.1 N HCl) at a much slower rate than 
starch-based materials in the initial stages of wetting but increased to higher 
rates in later stages (Botzolakis and Augsburger, 1988). The findings clearly 
demonstrated that crospovidone did not possess good capillary action (high 
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initial liquid absorption rate) but absorbed and retained considerable amounts 
of liquid at the later stages. Apart from liquid characteristics, capillary 
penetration rate (wicking) depends mainly upon particle wettability, geometry 
of capillary space, particle size, length of fibrous material and permeability of 
porous medium (Pillai and Advani, 1996). Crospovidone is composed of highly 
porous agglomerates and water could reside within the abundant internal pores. 
Thus it could have behaved as a repository for water. This may be the reason 
for the slow water movement and the observed reduced capillarity. On the other 
hand, capillary driven suction of liquid in MCC microfibril porous network was 
found to be highest which could be contributed by the hydrophilic nature of 
cellulose fibres.  
 
According to the present video imaging studies, SSG-E demonstrated a good 
swelling property with significant free particle motion and substantial capillary 
action. Disruptions of compacted particle bonds as well as free particle motion 
were highest for CCS. PGS also showed prominent swelling and wicking action. 
Free and compacted particles of MCC showed inappreciable swelling or 
instantaneous particle movements. However, MCC had the best capillary action 
amongst all the disintegrants studied. Thus, the mechanisms of action for all the 
disintegrants could be elicited by the use of video imaging. Free XPVP XL 
particles had neither significant swelling nor instantaneous motion on contact 
with water and compacts containing XPVP XL did not exhibit any substantial 
capillary action in comparison with MCC and starch-based disintegrants. 
Nevertheless, the instantaneous motion of separated particles from XPVP XL 
compact was quite considerable as with SSG-E and the other starch-based 
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disintegrants. As mentioned above, disintegrability of XPVP XL compacts 
increased with the application of compression pressure. The results of this study 
showed that the recovery of strain energy of compaction induced deformation 
is the major mechanism of disintegrant action of crospovidone and not 
capillarity-wicking or swelling. Based on these results and literature references, 
the theory of strain recovery of shape memory polymers (SMPs) is proposed for 
crospovidone disintegration. 
 
SMPs have the ability to revert to their original shape/geometry following 
deformation induced strains. A measured degree of cross-linking is required for 
SMPs to confer shape recoverability to the material (Khan et al., 2008; Leng et 
al., 2011). Crospovidone is also a cross-linked polymer prepared by popcorn 
polymerization (Shah and Augsburger, 2001). The hypothesis in this study was 
that the applied compression pressure deformed the crospovidone polymer 
matrix and recovery of crospovidone matrix shape upon wetting could be due 
to the plasticising effect of the water molecule on the polymeric chains, resulting 
in the release of strain energy stored in the deformed shape, which then 
increased the flexibility of the macromolecular chains. Here, the recovery 
process was initiated by the application of an external stimulus, water, which 
had enabled crospovidone chain mobility to revert to the original pre-
compression state. 
4.1.8  Understanding heat of interaction phenomenon of disintegrants 
and other excipients 
All disintegrants were found to be exothermic in nature. Exothermic properties 
of disintegrants could be attributed to the hydrogen bonding of disintegrant 
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polymer chains with water. Hydroxyl and hydroxymethyl groups of natural 
starch and cellulose polymers can form hydrogen bonds with water while 
hydroxyl, carboxymethyl and hydroxypropyl groups of modified starch and 
cellulose polymers form hydrogen bonds with water. In the case of 
crospovidone grades, carbonyl group of cyclic amide is responsible for 
hydrogen bonding (Schulz et al., 2010).  
 
Effects of the structural and constitutional changes of materials on the ΔH values 
were also observed. Amorphous materials are more exothermic than their 
crystalline counterparts. Modified starch and cellulose structures possess 
increased amorphous content and thus, more exothermic nature can be expected 
(Zografi and Kontny, 1986). Similar changes were identified from the results 
obtained. Pregelatinisation increased the exothermic properties of starch. 
Gelatinisation is the collapse (disruption) of molecular orders within the starch 
granule where irreversible changes in properties occur such as granular 
swelling, crystallite melting, loss of birefringence, viscosity development, and 
starch solubilisation. Starch is generally considered as a composite, in which 
swollen gelatinised granules, composed of mainly amylopectin, are embedded 
into an amylose matrix (Chaudemanche and Budtova, 2008). Typically, 
pregelatinised starch contains 5 % of free amylose, 15 % of free amylopectin 
and 80 % unmodified starch while the fully pregelatinised starch contains 20 - 
30 % amylose and the rest, amylopectin. Changes in the content of the starch 
constituents could be responsible for this enthalpy change. Properties of some 
excipients can be correlated with the obtained ΔH value. For example, sugar 
alcohols are known for producing a cooling sensation in mouth. The very high 
 98 
 
endothermic response observed with mannitol was related to the cooling 
sensation of mannitol. Results obtained suggested that polymer shape may have 
also affected the enthalpy changes of materials. It could be envisaged that the 
coiled polymers may not provide as much free bonding sites for interaction with 
water and hence, limited the potential thermodynamic activities on solvation 
like for the straight chain polymers. For compressed compacts of starch and 
cellulose, polymer-polymer hydrogen bonds should have been broken upon 
interaction with water, resulting in an increase in hydration and thus, more 
hydrogen binding sites. Changes in the swelling capacity or structural properties 
could be responsible for the reduced exothermic property of CCS after 
compression. This study was helpful in providing deeper insights into 
disintegrant-water interactions and their effects on the overall energetics. 
However, no clear relationship between the enthalpy change and disintegrant 
functionalities could be identified. For example, even though SSG-E and SSG-
P are superdisintegrants, their exothermic properties were not as high as those 
of crospovidone grades or CCS. Also ΔH values of L-HPC and HPC-SL were 
similar. L-HPC is a good disintegrant whereas HPC-SL is a binder. Thus, the 
enthalpic properties of the disintegrants were more related to their constitutional 
and structural properties rather than disintegrant functionalities per se. It is 
difficult to separate the heat generated due to multiple simultaneous processes 
(particularly structural changes, capillary forces, local crystallization) when free 
disintegrant particles or disintegrant compacts come in contact with water. This 
explains also the lack of correlation between heat of interaction and disintegrant 
functionality. Based on these results, it was concluded that the heat of 
interaction could not be a major mechanism for disintegrant action despite of 
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being listed as one of the mechanisms of action of disintegrants (Matsumara, 
1959). However, better understanding of the heat of interaction phenomena 
would definitely assist in formulation design by elucidating the possible 
synergistic choice of excipients (including disintegrants).    
4.2 Development of visiometric liquid jet mediated disintegration 
apparatus for studying RDT disintegration 
Disintegration apparatus-I was fabricated and used first to evaluate RDT 
disintegration. Subsequently, disintegration apparatus-II was developed to 
address a few of the limitations of disintegration apparatus-I 
4.2.1 Disintegration apparatus-I 
4.2.1.1 CFD results 
The CFD technique used was validated by comparing the generated velocity 
magnitude and total pressure contour plots of the disintegration compartment 
with experimental observations obtained from the fabricated disintegration 
compartments. In the simulated CFD design of the first disintegration 
compartment prototype design A (Figure 16), a central low velocity domain was 
evident in the internal chamber at a height of 0.5 mm (Figure 34A) but no such 
low velocity domain was observed at 4 mm (Figure 34B). Thus, the CFD design 
predicted a low velocity domain in the central region of the internal chamber 
near the base. Total pressure contour plot at 0.5 mm height (Figure 35A) showed 
negative pressure domains near the three outlets which were responsible for 
draining the disintegrated fragments along with the disintegration medium. 
Small negative pressure domains were also observed below the three inlet tubes 
inside the internal chamber (at 0.5 mm height) which had resulted in observed 
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accumulation of some disintegrated particles during the disintegration tests. 
Uniform positive pressure distributions were observed in the total pressure 
contour plot obtained at 4 mm height (Figure 35B). CFD results were confirmed 
during disintegration tests using this compartment as some disintegrated 
particles accumulated in the central region of the internal chamber (Figure 36A).  
 
Figure 34. Velocity magnitude contour plots of the disintegration compartment 
(A) design A at 0.5 mm height, (B) design A at 4 mm height, (C) design B at 
0.5 mm height, (D) design B at 4 mm height, (E) design C at 0.5 mm height and 




Figure 35. Total pressure contour plots of the disintegration compartment (A) 
design A at 0.5 mm height, (B) design A at 4 mm height, (C) design B at 0.5 
mm height, (D) design B at 4 mm height, (E) design C at 0.5 mm height and (F) 
design C at 4 mm height 
The CFD findings and experimental results led to the modifications in the 
design of the internal chamber by introducing 3 baffles as shown in 
compartment design B (Figure 16B). The baffles were inserted to direct the 
disintegration medium flow towards the low velocity region of the internal 
chamber. The contour plot of velocity magnitude at 0.5 mm height (Figure 34C) 
now showed that the central low velocity domain was reduced but the design 
left a negative pressure zone at the wake region of each baffle (Figure 35C). 
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Uniform velocity and positive pressure distributions were found in the internal 
chamber at 4 mm height (Figure 34D, Figure 35D). Results obtained from the 
simulation were confirmed from the observations during the disintegration 
study. Particles stopped settling at the central region of the internal chamber but 
gathered at the wake of the three baffles instead (Figure 36B).  
 
Figure 36. Accumulation of the disintegrated particles (A) in the central region 
of the internal chamber (design A) and (B) at the wake of the three baffles 
(design B) 
Based on the findings using compartment design B, the design was further 
modified by building embankments behind the baffles using silicone to 
eliminate the negative pressure zones (Figure 16C). The total pressure contour 
plot of design C at 0.5 mm height (Figure 35E) showed no negative pressure 
zones in the internal chamber. Velocity and positive pressure distributions were 
even in the internal chamber at 4 mm height (Figure 34F, Figure 35F). The 
actual experimental study with design C affirmed that the disintegrated particles 
were either absent or present in very small quantities at the base of internal 
chamber. If present, the particles were settled and evenly distributed. This could 
be attributed to good mixing at the low velocity region at 0.5 mm height (Figure 
34E) in the internal chamber. With compartment design C, RDT disintegration 




4.2.1.2 RDT disintegration time measurement 
Compartment design C was used for the determination of the disintegration 
times of 6 different types of commercial RDTs. Figure 37 shows a typical 
example depicting the disintegration of RDT sample at different time points. 
Among all the types of RDTs studied, break-up of RDT into smaller fragments 
(Figure 38A) was observed for sample types i, v and vi. A smooth layer of 
partially dissolved RDT components was observed on the periphery of the type 
ii RDT (Figure 38B) before break-up into smaller particles. Upper layer of the 
tablet was first separated before complete disintegration of type iii RDT (Figure 
38C). Swelling of disintegrating RDT fragments were observed in the case with 
type iv RDT (Figure 38D). Finally, all the disintegrated RDT fragments were 
removed from the internal chamber by the disintegration medium flow and 
disintegration time was determined for all the types of RDTs investigated. 
Comparison was made between the disintegration times obtained by the 
disintegration apparatus-I and the USP disintegration apparatus. Figure 39 
provides the mean disintegration times obtained for the various types of RDTs 
using USP disintegration apparatus and disintegration apparatus-I. Relative 
standard deviation (RSD) values of the disintegration times were also calculated 
as a measure of precision. Disintegration times ranged from 24 s to 140 s for the 
designed RDT disintegration apparatus with RSD in the range of 5 to 9.7 % and 
from 10 s to 86 s with RSD in the range of 7 to 27 % for USP disintegration 
apparatus. Thus, the results obtained by the designed RDT disintegration 
apparatus had remarkably smaller RSD than the results obtained by the USP 













Figure 38. Video images showing different disintegration patterns of RDT (A) 
break-up into smaller fragments, (B) partial component dissolution near tablet 
surface, (C) separation in layers and (D) swelling of disintegrating particles 
 
Figure 39. Disintegration times of RDTs using USP disintegration apparatus (■) 




























A strong correlation was obtained (Figure 40) between the disintegration time 
obtained by the designed RDT disintegration apparatus and the USP 
disintegration apparatus (coefficient of determination, R2 = 0.9386, correlation 
coefficient, r = 0.9688, 90 % confidence interval = 0.808 - 0.995, 95 % 
confidence interval = 0.736 - 0.996, two tailed probability, p = 0.00144). The 
small p value also indicated the significance of relationship. 
 
 
Figure 40. Relationship between disintegration times obtained by disintegration 
apparatus-I and USP disintegration apparatus 
US-FDA’s guidance on RDTs recommends the use of USP method for 
disintegration testing or other methods that yield results demonstrating good 
correlation with results obtained by USP method (US-FDA, 2008). Difficulties 
were often experienced when determining disintegration time of RDT using the 
USP disintegration apparatus due to the rapidness of the disintegration process. 
Pharmacopoeial disintegration testing involves a vertical dipping action which 
attributes to different stresses on the dosage form as the holding tube moves. 












































Disintegration time (s) - USP disintegration apparatus
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effect of variations in stresses on a disintegrating dosage form is not profound 
but for a dosage form that disintegrates in seconds, applied stress has best to be 
continuous and regular. Thus, any acceptable proposed apparatus should 
address the limitations of the official method. The disadvantage of a previously 
developed method of evaluating RDT disintegration time using CCD camera 
was that the method was unable to apply any mechanical stress to the RDT 
(Morita et al., 2002). Thus, the disintegration times of RDTs were generally of 
several minutes. Disintegrated particles of large size RDT could not 
instantaneously pass through the perforated holes of stainless plates and 
clogging of the perforated holes was observed by Harada et al. (2006) in their 
disintegration apparatus. In disintegration test performed using texture analyser 
instrument, upper surface of the tablet was attached using a tape (El-Arini and 
Clas, 2002). This upper surface was thus unavailable to come in contact with 
the disintegration medium. Also, the thickness of adhesive tape may affect the 
distance travelled by the probe and this may cause some errors in the 
measurements (Abdelbary et al., 2005).  
 
For the liquid jet mediated visiometric RDT disintegration apparatus designed, 
the angular water flow applied as 3 inlet jets, created shear stresses on the 
cylindrical side surface of the RDT. Therefore, the disintegration times obtained 
using this designed apparatus were generally shorter but adjustable by changing 
the flow rate of liquid input. As such, the developed disintegration apparatus 
can provide a universal approach to determine the disintegration time of any 
dosage form including RDT. Thus, the liquid jet-mediated disintegration in 
combination with precise visiometric determination of very short disintegration 
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times was found to be more suitable than the conventional USP method for 
disintegration testing. 
4.2.1.3 Limitations of the disintegration apparatus-I 
The final fabricated design of disintegration apparatus-I is still complicated and 
would be cumbersome to manufacture. Also, RDTs with diameter more than 10 
mm could not be comfortably placed into the disintegration compartment 
because of the limited space available in the compartment. Thus, the 
disintegration medium inlet and complicated compartment design specifications 
need to be modified in order to achieve an effective disintegration apparatus 
with a simple and scalable design. Based upon these requirements, 
disintegration apparatus-II was fabricated and the results obtained by this 
apparatus are discussed in section 4.2.2. 
4.2.2 Disintegration apparatus-II 
This study was conducted in 2 phases. Six different types of commercial RDTs 
and one type of laboratory manufactured placebo RDTs were used to test and 
validate the viability of the fabricated disintegration apparatus-II in the first 
phase of the study. Flow rate suitable to study RDT disintegration was optimised 
and disintegration times of RDTs were measured. In the second phase of the 
study, 117 types of laboratory manufactured RDT formulations (with 
disintegration time < 3 min as determined using the USP disintegration 
apparatus) were tested to further confirm the suitability of RDT disintegration 





4.2.2.1 First phase of the study 
4.2.2.1.1 Optimisation of flow rates 
Five different flow rates (48 mL/min, 74 mL/min, 97 mL/min, 120 mL/min and 
146 mL/min) were employed to identify the optimum flow rate of the 
disintegration medium into the disintegration compartment. Complete 
disintegration of RDT was not observed when a flow rate of 48 mL/min was 
used. The flow rate was not sufficient to disintegrate the tablet mass and remove 
the disintegrated tablet fragments from the disintegration compartment. 
Complete disintegration and removal of tablet fragments were observed when 
flow rates of 74 mL/min and 97 mL/min flow were used. With flow rates of 120 
mL/min and 146 mL/min, swirling of the tablet core was observed for some 
time before complete disintegration. Disintegration measurements of three 
different RDTs (inscribed as a, b and c) were performed using the fabricated 
disintegration apparatus at flow rates of 74 mL/min and 97 mL/min (Figure 41).  
 
Figure 41. Disintegration time of RDTs measured using disintegration 

























Flow rate - 74 mL/min
Flow rate - 97 mL/min
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RSD of disintegration time was calculated as a measurement of precision. 
Smaller RSD (in the range of 6.1 % - 18.4 %) was observed with flow rate of 
97 mL/min in comparison with 74 mL/min (in the range of 7.5 % - 29.6 %). 
Therefore, 97 mL/min was chosen as the optimised flow rate for disintegration 
study using the new fabricated disintegration apparatus.   
 
The velocity streamlines obtained from the simulated design of disintegration 
apparatus-II were analysed. As can be seen from Figure 42, sufficient swirling 
movement of water could not be generated at a flow rate of 48 mL/min. The 
streamlines suggest that a very high swirling (circular) pattern was generated at 
flow rate of 120 mL/min and above. This further explained why the tablet core 
swirled for some time before complete disintegration. According to these 
simulations, swirling just started at flow rate of 74 mL/min and optimal swirling 
could be observed at flow rate of 97 mL/min. Thus, the simulated flow analysis 
further verified the choice of 97 mL/min as the optimum flow rate. 
4.2.2.1.2 RDT disintegration time measurement 
Disintegration times of the 7 different types of RDTs (inscribed as a to g) were 
measured using the fabricated disintegration apparatus-II with flow rate of 97 
mL/min. Figure 43 shows a typical example depicting the disintegration of RDT 
sample at different time points. Sometimes, a transparent cover was fixed 5 mm 
above the disintegration cell so that the occasional bubble formation could be 



















Figure 44 presents the disintegration times of the different types of RDTs 
determined using the disintegration apparatus-II and the USP disintegration 
apparatus. A strong correlation (R2 = 0.9584) was obtained between the 
disintegration times obtained using both apparatus (Figure 45). Smaller RSD (in 
the range of 3.6 - 19.9 %) was observed for the results obtained using 
disintegration apparatus-II compared USP disintegration apparatus (in the range 
of 5.6 - 26.7 %), suggesting a better precision in measurement. 
4.2.2.2 Second phase of the study 
In the second phase of the study where disintegration times of 117 RDT 
formulations were measured, strong correlation was obtained between the mean 
disintegration time obtained using disintegration apparatus-II and the USP 
disintegration apparatus (Figure 46). 
 
Due to the rapidness of the disintegration process, it is sometimes difficult to 
determine the disintegration time of RDTs using USP disintegration apparatus. 
The study (performed in two phases) demonstrated that the fabricated 
disintegration apparatus-II is a more accurate and suitable alternative for 
studying RDT disintegration. In addition, capturing of the disintegration action 





Figure 44. Disintegration time of RDTs measured using USP disintegration 
apparatus (■) and disintegration apparatus-II (□) (First phase of the study) 
 
Figure 45. Relationship between disintegration times obtained by disintegration 








































































Figure 46. Relationship between disintegration times obtained by disintegration 
apparatus-II and USP disintegration apparatus (Second phase of the study) 
 
4.3 Assessment of functionalities of disintegrant mixtures in RDT 
formulations by a QbD approach 
4.3.1 Disintegration time and hardness models for aspirin RDTs 
Disintegration time of aspirin RDTs fitted best to a combined reduced quadratic 
x linear model (for mixture components and compression pressure 
respectively). Results of ANOVA are given in Table 5. The generated model 
reached statistical significance, with non-significant lack of fit, high Adeq 
precision value and a predicted R2 value that was in reasonable agreement with 
the adjusted R2 value. Hardness of aspirin RDTs was also described by a 
combined reduced quadratic x linear model. The model was significant, lack of 
fit was non-significant, predicted R2 value was in reasonable agreement with 
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Table 5. Results of ANOVA for aspirin, ascorbic acid and ibuprofen RDTs 










233.19 14 16.66 148.55 <0.0001 0.79 0.97 0.96 38.42 
(4.49) (40) (0.11)       
Hardness 
159.81 16 9.99 59.52 <0.0001 0.48 0.95 0.91 23.07 




3442.21 22 156.46 6.69 <0.0001 0.20 0.79 -3.65 12.01 
(724.79) (31) (23.38)       
Hardness 
7093.67 32 221.68 36.78 <0.0001 0.71 0.96 undefined 21.81 




19556.86 33 592.63 222.66 <0.0001 0.44 0.99 -1.58 44.48 
(55.89) (21) (2.66)       
Hardness 
8406.72 11 764.25 18.53 <0.0001 0.91 0.78 0.71 18.34 
(1773.94) (43) (41.25)       
                SS - sum of squares; df - degrees of freedom; MS - mean of squares; F - Fischer’s ratio; R2 - regression coefficient.  







The model that describes the relationship between disintegration time, tablet 
composition and compression pressure is as follows: 
Ln(disintegration time)
=  8.22𝑎 +  7.12𝑏 +  2.91 𝑐 +  2.89𝑑 +  2.38𝑒 −  8.68𝑎𝑐 
−  8.67𝑎𝑑 −  13.42𝑎𝑒 −  9.74𝑏𝑐 −  6.8𝑏𝑑 −  10.13𝑏𝑒 
+  0.66𝑏𝑓 −  3.9𝑐𝑑 +  0.36𝑐𝑓 −  4.4𝑑𝑒  
 (Equation 8) 
The relationship between hardness, tablet composition and compression 
pressure is described as follows: 
√Hardness =  4.86𝑎 +  4.65𝑏 +  3.69𝑐 +  0.62𝑑 
+  4.4𝑒 –  3.04𝑎𝑐 –  7.94𝑎𝑑 –  2.65𝑎𝑒 +  0.79𝑎𝑓 
−  3.19𝑏𝑐 –  6.79𝑏𝑑 +  0.81𝑏𝑓 −  5.26𝑐 𝑑 +  0.76𝑐𝑓 
−  5.11𝑑𝑒 +  0.88𝑒𝑓  
 (Equation 9) 
where 𝑎 is mannitol, 𝑏 is MCC, 𝑐 is SSG-P, 𝑑 is XPVP CL-SF, 𝑒 is CCS and 𝑓 
is compression pressure 
4.3.2 Disintegration time and hardness models for ascorbic acid RDTs 
Disintegration of ascorbic acid RDTs had a combined reduced quadratic x linear 
model. The generated model reached statistical significance, with non-
significant lack of fit (Table 5). The predicted R2 value was negative, implying 
that the overall mean was a better predictor of disintegration time than the 
generated model. High Adeq precision value suggested that the model can be 
used to predict the desired DS. Hardness of ascorbic acid RDTs followed a 
combined reduced quadratic x quadratic model with desirable ANOVA results. 
The equation that describes the relationship between disintegration time, tablet 




=  58.56𝑎 + 14.45𝑏 + 30.66𝑐 + 19.32𝑑 + 16.13𝑒 − 76.03𝑎𝑏
− 79.51𝑎𝑐 − 114.28𝑎𝑑  − 103.24𝑎𝑒 + 42.19𝑎𝑓
− 31.12𝑐𝑑𝑎𝑏 − 52.51𝑓𝑎𝑐 − 56.16𝑓𝑎𝑑 − 84.4𝑓𝑎𝑒 − 83.81𝑓  
 (Equation 10) 
The relationships between hardness, tablet composition and compression 
pressure can be described by: 
Hardness = 22.57𝑎 + 23.53𝑏 + 28.29𝑐 + 13.97𝑑 + 23.01 𝑒 − 19.03𝑎𝑑
+ 6.2𝑎𝑓 + 9.3𝑏𝑓 + 51.36𝑐𝑑 − 40.78𝑐𝑒 + 11.7𝑐𝑓 + 31.96𝑑𝑒
+ 12.18𝑑𝑓 + 12𝑒𝑓 + 29.25𝑏𝑐𝑓 + 24.71𝑏𝑒𝑓 + 24.94𝑑𝑒𝑓
− 10.99𝑎𝑓𝑓 − 9.12𝑏𝑓𝑓 − 14.71𝑐𝑓𝑓 − 10.57𝑒𝑓𝑓𝑐𝑑
− 55.57𝑓𝑓𝑐𝑒 + 39.37𝑓𝑓 
 (Equation 11) 
where 𝑎 is mannitol, 𝑏 is MCC, 𝑐 is SSG-P, 𝑑 is XPVP CL-SF, 𝑒 is CCS and 𝑓 
is compression pressure 
4.3.3 Disintegration time and hardness models for ibuprofen RDTs 
The disintegration behaviour of ibuprofen RDTs was described by a combined 
reduced quadratic x quadratic model. Results of ANOVA are given in Table 5. 
The model reached statistical significance and had non-significant lack of fit. 
The predicted R2 value was negative. High Adeq value was achieved. Hardness 
of ibuprofen RDTs had a combined reduced linear x quadratic relationship. The 
model was statistically significant with high Adeq precision value. Lack of fit 
was non-significant and the predicted R2 value was in reasonable agreement 
with the adjusted R2 value. 
 
The model that describes the relationship between disintegration time, tablet 
composition and compression pressure is as follows:  
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√Dsintegration time  
= 60.23𝑎 + 60.74𝑏 + 22.12𝑐 + 3.77𝑑 + 15.75𝑒 − 44.04𝑎𝑐
− 75.2𝑎𝑑 − 90.21𝑎𝑒 − 74.73𝑏𝑐 − 68.88𝑏𝑑 − 87.97𝑏𝑒
− 10.75𝑐𝑑 + 7.01𝑐𝑓 − 9.17𝑑𝑒 + 3.07𝑑𝑓 + 5.28𝑒𝑓
+ 26.74𝑎𝑐𝑓 + 29.15𝑎𝑑𝑓 + 19.13 𝑎𝑒𝑓 + 19.11𝑏𝑐𝑓
+ 25.94𝑏𝑑𝑓 + 19.92𝑏𝑒𝑓 − 12.79𝑐𝑑𝑓 − 5.75𝑐𝑓𝑓
− 4.97𝑒𝑓𝑓𝑎𝑑 + 53.27𝑓𝑓 𝑏𝑑 + 24.22𝑓𝑓 
 (Equation 12) 
The relationship between hardness, tablet composition and compression 
pressure is described as follows: 
Hardness = 53.38𝑎 + 61.79𝑏 + 63.01𝑐 + 45.14𝑑 + 82.47𝑒 + 14.21𝑎𝑓
+ 10.27𝑏𝑓 + 14.81𝑑𝑓 + 13.9𝑒𝑓 − 15.69𝑒𝑓𝑓 
 (Equation 13) 
where 𝑎 is mannitol, 𝑏 is MCC, 𝑐 is SSG-P, 𝑑 is XPVP CL-SF, 𝑒 is CCS and 𝑓 
is compression pressure 
4.3.4 Validation of selected models 
Models for the disintegration time of aspirin, ascorbic acid and ibuprofen RDTs 
obtained were validated. The models for hardness of aspirin and ibuprofen 
RDTs were validated, and that for ascorbic acid RDTs was partially validated 
(the actual hardness in one of the three optimised formulations was outside the 
predicted hardness range so the model was termed partially validated). The 
predicted and actual values of the validation runs are given in Table 6 (99 % 
prediction interval, α = 0.01). The results confirmed that the validated models 
are good predictive tools. Also, output responses for input variables (within the 

















1 5.7 (3.2 - 10.1) 7.6 20.0 (13.5 - 27.8) 21.5 
2 5.9 (3.2 - 10.9) 8.9 23.0 (15.7 - 31.7) 23.6 
3 5.7 (3.5 - 9.4) 9.4 20.0 (15.2 - 25.4) 22.7 
Ascorbic acid 
1 12.7 (1.7 - 23.7) 14.9 20.0 (14.7 - 25.4) 15.5 
2 10.3 (2.9 - 17.7) 13.9 20.0 (16.2 - 23.8) 9.1 
3 10.1 (2.4 - 17.8) 14.1 20.0 (15.9 - 24.1) 17.2 
Ibuprofen 
1 13.7 (0.0 - 53.9) 35.7 46.1 (36.5 - 55.7) 45.0 
2 13.7 (0.4 - 46.1) 34.8 44.4 (35.5 - 53.2) 36.6 
3 6.8 (0.1 - 23.7)* 19.0 45.4 (36.8 - 54.0) 37.4 
DT - disintegration time; *95 % prediction interval (α = 0.05) as interval could 
not be generated at 99 % level 
 
Trends found using the validated models are discussed in subsequent sections. 
Contour plots, overlay plots and relevant trends are provided to support the 
discussions wherever possible. 
4.3.4.1 Effects of individual disintegrants on RDT disintegration 
SSG-P and CCS have been known to cause lengthened disintegration times 
when used at high concentrations. This is likely due to the partial gelling 
tendency of the disintegrants that potentially cause the formation of a viscous 
barrier and delay the entry of water into the tablet (Bi et al., 1996; Haware et 
al., 2008). Similar results were observed for aspirin, ibuprofen and ascorbic acid 
RDTs for all compression pressures (88.7 MPa - 354.7 MPa range). SSG-P was 
optimal at 8 % in aspirin and ibuprofen RDTs, and at 6 % in ascorbic acid RDTs. 
CCS performed best at about 7 % in all 3 drug models. XPVP CL-SF was also 
observed to demonstrate similar effects especially for aspirin and ascorbic acid 
RDTs. Disintegration time decreased with an increase in XPVP CL-SF 
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concentration, until a minimum at 8 % for aspirin and ibuprofen RDTs, and 6 
% for ascorbic acid RDTs. The typical observed effects are presented in Figure 
47 at compression pressure 177.3 MPa. Decrease in disintegration time could 
also be due to the decrease in hardness of RDTs at that particular composition. 
For this particular example, the lowest hardness values (or range of values) have 
been included in Figure 47, depicted by closed circles. Aspirin RDTs had lowest 
hardness when single disintegrant, XPVP CL-SF was used in the range of 6.5 - 
8.5 %, SSG-P was used in the range of 6 - 8 % or CCS was used in the range of 
5.5 - 6.5 %. Thus, for aspirin RDTs, the lowest disintegration time at a particular 
disintegrant composition could be due to the decrease in the hardness value. 
However, for ibuprofen RDTs, the hardness was not low when the 
disintegration time decreased. Hardness was increased with increase in SSG-P 
and CCS concentration (more detailed discussion is provided in section 4.3.4.5). 
Hardness was not at the lowest point when the disintegration time was low. 
However, hardness decreased with increase in XPVP CL-SF and was lowest at 
the highest XPVP CL-SF amount. The model for hardness of ascorbic acid 
RDTs was partially validated and therefore hardness and disintegration time 
relation for ascorbic acid RDTs is not discussed. 
4.3.4.2 Effect of compression pressure on RDT disintegration time 
The effect of compression pressure on RDT disintegration time was studied for 
the optimal individual disintegrant concentration (mentioned in section 4.3.4.1). 
Generally, increase in compression pressure increased the disintegration times 
of RDTs or had no significant effect on the disintegration times of RDTs. This 
typical observed effect is presented in Figure 48A for aspirin RDTs when SSG-




Figure 47. Effects of disintegrant concentration on disintegration time of (A) 
aspirin, (B) ibuprofen and (C) ascorbic acid RDTs (compression pressure, 177.3 






Figure 48. Effects of compression pressure on disintegration time of (A) aspirin 
(8 % SSG-P) and (B) ibuprofen (8 % XPVP CL-SF) RDTs 
However, XPVP CL-SF and CCS showed different trends in selected cases. 
When XPVP CL-SF alone was used at its optimal concentration (8 %), 
disintegration time of ibuprofen RDTs decreased with increase in compression 
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pressure (up to 177.3 MPa) and then increased again with increase in 
compression pressure (Figure 48B). This particular effect could be due to the 
strain recovery mechanism of XPVP CL-SF. For ascorbic acid RDTs, increase 
in compression pressure decreased the disintegration time when CCS and XPVP 
CL-SF were used at their optimal concentrations (7 % and 6 % respectively). 
 
4.3.4.3 Synergism between disintegrants 
It is possible for synergism to occur between disintegrants with different 
mechanisms of action. For example, a swelling disintegrant may be 
complemented by another that draws in water. Since each disintegrant has been 
reported to have various mechanisms of action, it is conceivable that synergism 
behaviour would occur with concurrence of reinforcing disintegration 
mechanisms or improvements in the physicochemical microenvironment for 
rapid disintegrant action. 
 
Synergism was observed between SSG-P and XPVP CL-SF in aspirin RDTs at 
all modelled compression pressures from 4 to 10 % of the total disintegrant 
concentration. A typical graph depicting the synergism is given in Figure 49A 
at 354.7 MPa compression pressure. The swelling and wicking abilities of SSG-
P appeared to contribute positively to the strain recovery effect of XPVP CL-
SF, decreasing total disintegration time. 
 
A similar behaviour was observed for ibuprofen RDTs between CCS and XPVP 
CL-SF at 354.7 MPa compression pressure (Figure 49B). However, the effect 
was not seen at other modelled compression pressures. The effect became 
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significant from 8 to 10 % of the total disintegrant concentration. Again, the 
viscoelastic recovery of XPVP CL-SF under high strain might be important in 
synergism with CCS in this case. 
 
Figure 49. Effects of (A) SSG-P - XPVP CL-SF composite concentration on 
aspirin RDTs disintegration time and (B) XPVP CL-SF - CCS composite 





4.3.4.4 Disintegrant optimisation 
All tested RDTs had shorter disintegration times if CCS was used instead of 
SSG-P. Figure 50 demonstrates this effect for RDTs pressed at 177.3 MPa 
compression pressure. The phenomenon was more prominent at higher 
compression pressures. The observation showed that CCS performed as a 
disintegrant better than SSG-P under the experimental conditions used. No 
synergism was seen between CCS and SSG-P. 
 
Ascorbic acid RDTs had improved disintegration times when MCC was used 
instead of SSG-P at all compression pressures. Figure 51A depicts the effects 
of SSG-P - MCC composite concentration on the disintegration time of ascorbic 
acid RDTs prepared at 354.7 MPa compression pressure. MCC provided the 
capillary network for water intake into the tablet. The combined effect of 
extensive water entry with rapid dissolution of highly soluble ascorbic acid 
enhanced the swelling effect of SSG-P. This trade-off between SSG-P and MCC 
combination was similar to that between SSG-P and XPVP CL-SF. 
Disintegration was improved by using XPVP CL-SF in comparison with SSG-
P. Figure 51B depicts the effects of SSG-P - XPVP CL-SF composite 
concentration on the disintegration time of ascorbic acid RDTs prepared at 
354.7 MPa compression pressure. 
4.3.4.5 Effect of disintegrant compositions on RDT hardness 
Hardness of aspirin RDTs decreased when the disintegrant proportion 
increased. However, a minimum existed, after which hardness values increased 




Figure 50. Effects of SSG-P - CCS composite concentration on disintegration 
time of (A) ascorbic acid, (B) aspirin and (C) ibuprofen RDTs (compression 





Figure 51. Effects of (A) SSG-P - MCC composite concentration and (B) SSG-
P - XPVP CL-SF composite concentration on disintegration times of ascorbic 
acid RDTs (compression pressure, 354.7 MPa) 
 
or CCS was used at 6 % and when SSG-P was 7 % (Figure 52). Relating the 
disintegration time (Figure 47) and hardness value (Figure 52), the 
disintegration time range of aspirin RDT was lowest when hardness range was 
low (also depicted by closed circles in Figure 52). On the other hand, hardness 
varied linearly with disintegrant concentration in ibuprofen RDTs. CCS, SSG-
P and MCC increased hardness when used at higher concentrations while XPVP 
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CL-SF lowered hardness as the concentration was increased. For ibuprofen 
RDTs, disintegration time was not decreased at lower hardness values. 
 
Figure 52. Effects of disintegrant concentration on hardness of (A) aspirin and 
(B) ibuprofen RDTs (compression pressure, 177.3 MPa) 
The decrease in hardness with XPVP CL-SF was possibly due to the relative 
lack of hydrogen bonding sites, and hence, decreased the overall bond strength 
between tablet constituents. Cellulose excipients are generally good for 
hydrogen bonding. Therefore, increase in CCS, SSG-P and MCC concentration 




Hardness values of aspirin RDTs were lower when MCC was combined with 
SSG-P than when either disintegrant used alone (Figure 53A). Hardness was 
lowest when SSG-P was used alone as compared to MCC and CCS. The best 
tablet hardness values with a single component disintegrant were achieved using 
MCC. Ibuprofen RDTs displayed a different relationship between tablet 
hardness and the disintegrant concentration used. Tablets formulated with CCS 
had the highest hardness values while those containing MCC or SSG-P had 
similar hardness values. Figure 53B shows the effects of MCC-CCS 
disintegrant composites on ibuprofen RDTs at 177.3 MPa compression 
pressure. 
4.3.4.6 Formulation optimisation 
Overlay plots of aspirin, ibuprofen and ascorbic acid RDTs were studied to 
determine the disintegrant attributes and compression pressure from which 
robust fast disintegrating and sufficiently hard tablets can be produced. For 
aspirin RDTs, MCC - CCS, SSG-P - CCS and XPVP CL-SF - CCS composite 
combinations at higher compression pressures (221.7 - 354.7 MPa) provided 
acceptable output responses. Here, the main disintegrant proposed was CCS at 
4 % or more. The use of other disintegrants would be optional. Figure 54A 
shows a sample overlay plot for aspirin RDTs depicting an acceptable region 
(white region) of CCS - SSG-P composite combination requirements at 354.7 
MPa compression pressure to produce RDTs with the required output responses. 
Areas that did not meet the feasible output response criteria are shaded grey. 
Overlay plots for other disintegrant composite combinations at different 




Ibuprofen RDTs had sufficient hardness even when prepared with 88.7 MPa 
compression pressure. Low melting point (75 - 77°C) of ibuprofen could be 
responsible for particle-particle fusion while compressing ibuprofen RDTs, 
leading to stronger tablets (Di Martino et al., 2002; Le et al., 2006). The 
suggested single disintegrant for ibuprofen RDTs was CCS (≥ 4.5 % at 
compression pressure 88.7 MPa) and disintegrant composite combinations for 
ibuprofen RDTs were SSG-P - XPVP CL-SF (compression pressure range, 88.7 
- 239.4 MPa), MCC - XPVP CL-SF (compression pressure range, 88.7 - 239.4  
 
Figure 53. Effects of (A) MCC - SSG-P composite concentration on hardness 
of aspirin RDTs and (B) MCC - CCS composite concentration on hardness of 




Figure 54. Overlay plots for the effect of disintegrant attributes on disintegration 
time and hardness of RDTs. (A) aspirin (compression pressure, 354.7 MPa), (B) 
ibuprofen (compression pressure, 88.7 MPa) and (C) ascorbic acid 
(compression pressure, 221.7 MPa) 
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MPa), MCC - CCS (compression pressure range, 88.7 - 133 MPa), SSG-P - 
CCS (compression pressure range, 88.7 - 133 MPa) and XPVP CL-SF - CCS 
(compression pressure range, 88.7 - 239.4 MPa). Figure 54B shows a sample 
overlay plot for ibuprofen RDTs depicting SSG-P - CCS composite 
combination requirements at 88.7 MPa compression pressure. 
 
For ascorbic acid RDTs, any two disintegrant composite combinations (total 4.5 
- 5 %) used in the study provided acceptable output responses when compressed 
in the range of 177.4 - 354.7 MPa. Here, the main disintegrants proposed were 
CCS (≥ 4.5 %) and MCC (≥ 5 %) which can produce acceptable ascorbic acid 
RDTs even when used alone.  Figure 54C shows a sample overlay plot for 
ascorbic acid RDTs depicting MCC - CCS composite combinations 
requirements at 221.7 MPa compression pressure. 
 
Based upon all the overlay plot analyses, the suggested optimised combinations 
of particular RDT formulations are reported in Table 7. 
 
Analysis of any 3 disintegrant combinations showed that the total disintegrant 
amount required was similar to single or combination of 2 disintegrants in 
providing acceptable outcome responses in any of the RDT formulations. Thus, 
either single disintegrant or combination of two disintegrants was suggested. 
The final decision may be considered based on relative excipient cost and 




Table 7. Optimised combinations of RDT formulations 






Aspirin CCS (4 %) 354.7 API (50 %), 
Mg St (0.5 
%), mannitol 
(45.5 %) 
DT: ≤ 15 s, 
Hardness: ≥ 
20 N  
Ibuprofen CCS (4.5 %) 88.7 API (50 %), 
Mg St (0.5 
%), mannitol 
(45 %) 





CCS (3 %),  
MCC (1.5 %) 
221.7 API (50 %), 
Mg St (0.5 
%), mannitol 
(45 %) 
DT: ≤ 15 s, 
Hardness: ≥ 
20 N 
















CHAPTER 5. CONCLUSIONS 





5 CONCLUSIONS AND FUTURE DIRECTIONS 
5.1 Investigation on functionalities of disintegrants 
High-speed video imaging technique was successfully used to study 
disintegration phenomena of major disintegrants used in tablet dosage forms. 
Video images and subsequent image analysis for the disintegration study were 
able to provide information relevant for analysing all the significant 
mechanisms of action of disintegrants. Analysis of the captured images 
provided an important analytical method to elicit the behaviour of excipients. 
From the results obtained, it was concluded that there was no significant 
swelling and capillary action associated with XPVP XL in free and compacted 
particles, respectively. The study findings strongly indicate that recovery of 
energy of strain deformation should be the major mechanism for XPVP XL 
disintegrant action. The disintegration behaviour of compacts containing 
crospovidone may be attributed to the shape-memory characteristics of 
crospovidone.  
 
The heat of interaction results obtained using solution calorimetry confirmed 
that all the disintegrants are exothermic in nature. However, heat of interaction 
is not a major mechanism driving tablet disintegration. The structural, 
constitutional, physical and chemical properties of disintegrants and other 
excipients had significant effect on the heat of interaction values. The results 
obtained using solution calorimetry expanded the understanding of the 
properties of disintegrants. 
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5.2 Development of visiometric liquid jet mediated disintegration 
apparatus for studying RDT disintegration 
The usefulness and applicability of the visiometric liquid jet mediated 
disintegration apparatus to assess RDT disintegration time were evaluated. CFD 
was used to examine the velocity and pressure distributions inside the RDT 
disintegration compartments. Velocity magnitude, total pressure contour plots 
and velocity streamlines generated by CFD were in close agreement with the 
experimental results. Thus, prediction of hydrodynamics at any point in the 
disintegration apparatus by CFD could explain the variability in experimental 
results and aid in design improvements. A good correlation was observed 
between the determined RDT disintegration times obtained by the designed 
visiometric RDT disintegration apparatus (I and II) and the USP disintegration 
apparatus. The designed RDT disintegration apparatus (I and II) together with 
the applied visualisation method enabled efficient and precise determination of 
the very short disintegration times of rapidly disintegrating dosage forms. The 
design of disintegration apparatus-II is simple and easily scalable. It can be used 
to accurately determine the disintegration times of RDT preparations and is 
suitable for routine quality control purposes. 
5.3 Assessment of functionalities of disintegrant mixtures in RDT 
formulations by a QbD approach 
RDTs incorporating APIs of different water solubilities were investigated for 
the effect of different disintegrants on disintegration time and tablet hardness. 
The disintegration models for aspirin, ibuprofen and ascorbic acid RDTs 
obtained using the USP apparatus were validated. Hardness modelling for 
aspirin and ibuprofen RDTs were also validated. SSG-P, CCS and XPVP CL-
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SF delayed disintegration when used at increased concentrations. SSG-P and 
XPVP CL-SF worked synergistically in aspirin RDTs to decrease disintegration 
time. Synergistic effects were also seen in ibuprofen RDTs with SSG-P - XPVP 
CL-SF and CCS - XPVP CL-SF mixtures at high compression pressures. SSG-
P could be replaced by CCS in all RDTs to reduce disintegration time, and to 
increase hardness in aspirin and ibuprofen RDTs. For highly water soluble API 
like ascorbic acid, the use of SSG-P increased disintegration time, while 
disintegrants such as MCC and XPVP CL-SF quickened disintegration. Overall, 
DOE and RSM proved to be important and useful tools for investigating the 
effect of disintegrant concentrations, disintegrant combinations and 
compression pressure on disintegration time and hardness of RDTs. This study 
serves as a model for product development based on the QbD framework with 
specifications of excipients in ranges within the designed acceptance space for 
optimal product performance. 
5.4 Future directions 
Based upon the PhD research work accomplished, the following future 
directions were suggested. 
 
Disintegrants were used as received in the investigations on functionalities of 
disintegrants by high-speed video imaging and solution calorimetry. However, 
for tablets prepared from high shear and fluid bed granules, disintegrants in the 
formulations may have been exposed to different drying and moisture 
conditions during granulation. Hence, studies could be conducted to investigate 
if the functionalities of disintegrants are affected by exposure to different 
moisture and drying conditions. With a better understanding of the behaviours 
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of disintegrants under different conditions, it may be possible to develop 
superior disintegrants. Designs of disintegrants or disintegrant combinations 
with improved disintegration properties could be explored.  
 
Solution calorimetry experiments proved that the functional and structural 
properties of disintegrants and other excipients can be well characterised by this 
tool. A thermodynamic model could be developed to investigate the tablet 
disintegration process. Such thermodynamic model will be able to assist the 
formulation ingredient selections optimally and thus help in refining the 
formulation development process. 
  
In the newly developed RDT disintegration apparatus-II, flow rate of 
disintegration medium can be easily controlled with the help of a programmable 
pump. Different types of tablet formulations (e.g. sublingual, buccal, 
conventional) come into contact with different amounts of disintegration 
medium at different flow rates in vivo. The usefulness of the developed 
disintegration apparatus-II for studying disintegration of these dosage forms 
should also be attempted. 
 
The study on functionalities of disintegrants and their mixtures by a QbD 
approach confirmed that the favourable blend of disintegrants in optimised 
ratios and amounts can enhance the disintegration rate of the formulation. 
However, using more than one disintegrant in the formulation may increase 
complexity in the manufacturing process. Co-processed disintegrants can be 
developed and used instead in the formulation composition. Carefully 
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engineered composite disintegrants at optimised ratios can produce 
formulations with optimal attributes, such as shorter disintegration rates and 
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